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ABSTRACT 
The biogenic amine hy~othesis of affective disorders 
ascribes a functional depletion of neurotransmitters within 
critical regions of the brain as either the cause or, at the 
very least, a concomitancy of the depressive syndrome. Much 
indirect evidence has accummulated to suggest that the ther-
apeutic effect of tricyclic antidepressants (TCA's) is med-
iated by their ability to block the re-uptake of physiologi-
cally released neurotransmitter leaving more neurotransmitter 
available within the synapse to interact with the post-synap-
tic receptor, thereby correcting the posited functional de-
pletion. 
The evidence upon which the proposed mechanism of TCA's 
therapeutic activity is based is largely indirect. ~ ost of 
the evidence comes from in-vitro studies of the ability of 
tricyclics to block neurotransmitter uptake into either 
brain slices, minces or preparations of pinched-off nerve 
endings (synaptosomes). The therapeutic response, however , 
cannot be demonstrated upon acute aQministration of these 
drugs and clinically effective activity is usually not ob-
·served until after several weeks of chemotherapy. The up-
take inhibitory characteristics which have been demonstrated 
in-vitro, therefore, cannot explain the latency to the ther-
apeutic effect. 
A time-course for the effect of protriptyline administra-
tion upon n3-l-norepinephrine (E3-l-NE) uptake into hypothal-
amic crude synaptosomal homogenate (CSH) was determined 
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after acute, sub-acute and chronic treatment . In addition, 
the ability of a number of TCA's to block the uptake of 
three biogenic amines, the catecholamines, norepinephrine 
and dopamine, and the indoleamine, serotonin, was assessed 
using a CSH in-vitro test system. 
The results support the biogenic amine hypothesis as 
well as the proposed mechanism of action of TCA's . Uptake 
blockade could be demonstrated after acute and chronic ad-
ministration but not after sub-acute administration. An 
attempt to describe some of the characteristic effects of 
individual TCA's as well as effects common to the class of 
drugs was approached on the basis of predominant neurotrans-
mitter influences. 
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CHAPTER I: INTRODUCTION 
2 
The biogenic a~ine hypothesis of affective disorders, 
admirably and extensively reviewed by Baldessarini (1975), 
was first proposed by Jacobsen in 1959 and popularized by 
Schildkraut and Kety (1967). The hypothesis developed from 
observations of the effects of drugs upon emotionality and 
the resultant biochemical changes produced by these drugs in 
experimental animals. Reserpine, once used widely in the 
treatment of essential hypertension, produces depression in 
a significant proportion of patients necessitating with-
drawal of the medication. Reserpine has also been shown to 
drastically deplete levels of physiologically active biogenic 
neurotransmitter amines within the brains of experimental 
animals. The biogenic amine hypothesis attributes lowered 
levels or turnover of these amines as either the cause or, 
at the very least, a concomitancy of the depressive syndrome. 
Further support for the hypothesis comes from the 
noted clinical antidepressant properties of a class of drugs 
referred to as monoamine oxidase inhibitors ( MAOI). Ipronia-
zid, an early member of the class, produced mood elavation 
in patients being treated for tuberculosis. Inhibition of 
MAO, an enzyme which degrades biogenic amines within the 
central nervous system (CNS), results in increased levels of 
the amines. Reviews of the support for the biogenic amine 
hypothesis abound (Davis, 1970; Schildkraut, 1973; Leonard, 
1975; Weil-Malherbe, 1972) and even some dealing selectively 
with either norepinephrine (Schildkraut, 1965), dopamine 
(McClure, 1973) or serotonin (Lapin and Oxenkrug, 1969) as 
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the critical neurotransmitter exist. 
Tricyclic antidepressants have been shown to be effect-
ive inhibitors of the primarily neurotransmitter-specific, 
"hi-affinity", uptake process which many investigators 
believe is responsible for the termination of activity of 
physiological concentrations of neurotransmitter at the 
synapse. The ability of these antidepressants to block the 
uptake of neurotransmitter from the synapse may result in 
more neurotransmitter available within the synapse to inter-
act with the post-synaptic receptor. This property of the 
drug would logically tend to reverse the effect of a lowered 
level or lowered potency or, in terms of the biogenic amine 
hypothesis, a functional depletion of neurotransmitter and 
can account for a reversal of the depressive symptoms. 
The onset of clinical antidepressant activity, however, 
cannot be explained by correlations with antidepressant 
plasma levels (Oswald, 1972). A lag of several weeks of 
treatment before antidepressant activity becomes apparent 
has been reported in clinical trials of tricyclic anti-
depressant therapy (Hammer, et al., 1962; Asberg et al., 
1970). Uptake studies to date deal primarily with in-vitro 
effects of antidepressants and in doing so cannot uncover 
any significant alterations in the drug effects on the uptake 
systems which might be coincident with and possibly related 
to the clinical antidepressant activity. Although one 
recent study (Ross and Renyi, 1975b) reports the effect of 
uptake blockade in animals treated for one day orally, there 
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has not been a study reporting the effect of chronic admini-
stration of tricyclics on the hi-affinity uptake system of 
biogenic amines in the central nervous system. The design 
of many antidepressant drugs and the animal screening models 
for potential new antidepressants relies heavily upon the 
uptake inhibitory property of the tricyclics. Although the 
property of uptake inhibition fits the heuristic biogenic 
amine hypothesis, it has yet to be established that the 
therapeutic effect is mediated by this mechanism either 
entirely or in part. 
A test of the hypothesis that tricyclic antidepressants 
mediate this therapuetic activity by inhibiting the uptake 
of biogenic amines can be approached experimentally using 
isolated pinched off nerve endings (synaptosomes) as a 
model of nerve endings functioning in-situ (Kuhar, 1973; 
Bradford, 1975). Characterization of the model and optimi-
zation of the parameters for unidirectional transport are 
the required preliminary experiments. The classical pharma-
cological approach necessitates establishing a time course 
for the effect as well as a dose-response curve. Treatment 
effects may then be compared with that of vehicle injected 
controls to conclude the test of this hypothesis. 
To confirm that uptake inhibition occurs upon repeated 
administration of tricyclics would lend support to the bio-
genic amine hypothesis and further substantiates the concept 
that tricyclics may mediate their effect by virtue of this 
well documented property. 
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CHAPTER II: REVIEW OF THE LITERATURE 
6 
A. Neurotransmitter inactivation by uptake processes: An 
historical background. 
Interest in measuring the uptake of catecholamines and 
the physiological significance of this process came about 
as a result of a number of experiments designed to illustrate 
the mechanism by which catecholamines are inactivated under 
physiological conditions. Monoamine oxidase (MAO) was then 
considered the enzyme responsible for inactivating the 
catecholamines at sympathetic nerve endings in much the same 
way in which acetylcholinesterase was thought to act at 
cholinergic neurons (Burn, 1953). Koelle and Valk (1954) 
reported that unlike acetylcholinesterase in cholinergic 
neurons, MAO is not selectively associated with adrenergic 
neurons. Kamijo et al. (1955), Balzer and Holtz (1956) and 
Corne and Graham (1957) all reported the inability of a 
variety of MAOI's to significantly potentiate the actions of 
catecholamines either administered exogenously or released 
by stimulation of the sympathetic nerve. 
Catechol-0-methyltransferase (COMT ) has been shown to 
play a role in the metabolism of catecholamines (Axelrod, 
1957, 1959; Hertting and Axelrod, 1961; Rosell et al., 1963), 
but Bacq (1959) reported only a slight potentiation of the 
effects of endogenous catecholamines produced by stimulation 
of sympathetic .nerves after COMT was inhibited by pyrogallol. 
Wylie et al. (1960) reported similar results upon admini-
stration of exogenous catecholamines as did Murnaghan and 
Mazurkiewicz (1963) using another COMT inhibitor, 4-methyl-
tropolone. 
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Burn (1932) first suggested that exogenously admin-
istered catecholamines might be taken up into storage sited 
of certain peripheral tissue, but it was not until fifteen 
years later that Raab and Humphreys (1947) reported an 
increase in catecholamine content of cat and dog hearts 
after the administration of large doses of epinephrine and 
norepinephrine. 
Acceptance of the importance of tissue uptake in the 
inactivation of catecholamines awaited the development of 
radioactively labeled catecholamines with high specific 
activity and this uptake was demonstrated by Axelrod et al. 
(1959). 3H-Epinephrine (O.l mg/kg) administered to mice 
was found to disappear in two phases. The first phase was 
a rapid metabolism of approximately 7CJ% of the injected 
dose. The remaining 30%, however, disappeared more slowly. 
The interpretation of these results was that exogenously 
administered catecholamines are accumulated in tissues and 
may serve to inactivate catecholamines under normal physic-
logical conditions. Whitby et al. (1961) drew the same 
conclusions from the res1~lcs of similarly designed experi-
ments. Further support for the concept of uptake being 
responsible for inactivation of catecholamines came from 
Muscholl (1961) using a combination of bioassay and flouri-
metric techniques and from the laboratory of Stromblad and 
Nickerson (1961) as well. Numerous reports substantiating 
this conclusion followed and are reviewed by Iversen (1965). 
Considerable evidence has accumulated to suggest that 
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the uptake of catecholamines occurs into post-ganglionic 
nerve endings. Kopin et al. (1964) maintained that if 
allowances are made for differences in regional blood flow 
through various tissues studied, there is a good correla-
tion between the accumulation of norepinephrine and the 
level of endogenous norepinephrine. The levels of endog-
enous norepinephrine may be taken to reflect the extent of 
innervation of the organ or tissue by sympathetic post-
ganglionic terminals, although turnover may be judged a 
better indicator by some (Costa, 1969). Additional evidence 
that the uptake of norepinephrine occurs primarily into 
sympathetic post-ganlionic neuronal endings became available 
when Hertting et al. (1961) reported almost complete dis-
appearance of the ability of norepinephrine and epinephrine 
to accumulate in tissues in which the sympathetic post-
ganglionic nerves innervating the tissue had been cut and 
the terminals allowed to degenerate. This approach was 
modified by Zaimis et al. (19 65), Iversen et al. (1966) and 
Sjoqvist et al. (1967) whereby sympathetic innervation was 
obliterated by immunosympathectomy at birth; the results 
obtained were similarly interpreted. 
A number of techniques have been employed to conclude 
that localization of accumulated radiolabeled norepinephrine 
occurs predominantly in neuronal endings include studies 
using density gradient centrifugation (Potter and Axelrod, 
1962; 1963), autoradiography and electron microscopy (Werle 
et al., 1962; ~arks et al., 1962; Samorajski et al., 1964) 
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and histochemical flourescence techniques (Hamberger et al., 
1964). Although the evidence implicates the neuronal 
ending as the site of uptake, methodology at that time was 
not available to accurately separate and describe the com-
ponent of uptake into tissue other than neuronal endings. 
Fischer and Kopin (1964), however, did present evidence to 
indicate that the uptake of catecholamines was not limited 
to neuronal tissue in their report describing uptake into 
denervated salivary glands of the rat. 
Further elaboration of the characteristics of uptake 
systems of peripheral tissues came about as a result of 
attempts to study the effects of drugs. Macmillan (1959) 
proposed the "nerve uptake hypothesis" ascribing the poten-
tiating properties of cocaine to its ability to interfere 
with the catecholamine uptake mechanism. Adrenergic 
blocking agents were found to inhibit the uptake of 3H-
norepinephrine including phenoxybenzamine and dicholro-
i soproterenol (Axelrod et al., 1962b). Tricyclic anti-
depressants, neuroleptics of the phenothiazine class as 
well as guenethidine, bretylium and ouabain were shown to be 
effective inhibitors of the noradrenergic uptake mechanism 
(Axelrod et al., 196lb; Herhitting et al., 1962; Dengler et 
al., 1962) as well as the sympathomimetic amines tyramine, 
amphetamine and ephedrine (Axelrod and Tomchick, 1960; 
Axelrod et al., 196la, Heritting et al., 1962; Dengler et al. 
1961). 
Muscholl (1960), Axelrod et al. (196lb) and Heritting 
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et al. (1962) all reported that reserpinized tissues failed 
to accumulate epinephrine and norepinephrine. Dengler (1961) 
found that the accumulation of epinephrine and norepin-
ephrine in tissue slices was prevented when reserpine was 
present in the incubation medium . As a result of these 
experiments there was relatively wide acceptance that reser-
pine inhibited the uptake of catecholamines (Brodie and 
Beaven , 1963). After an extensive review of the literature, 
however , Shore (1963) concluded that the actions of reser-
pine were predominantly centered around the intracellular 
uptake and storage mechanism and not the neuronal membrane 
uptake system. Direct evidence to support this hypothesis 
came from Lindmar and Muscholl (1964) where in both normal 
and reserpinized is~lated rat heart preparations, they 
infused 0.5 ug of norepinephrine over a 10 minute period 
and collected and analyzed the perfusate for unchanged 
norepinephrine. Analyzing the norepinephrine content of 
the heart after the perfusion interval, they determined that 
in normal hearts the catecholamine taken up from the medium 
was almost entirely accounted for as unchanged norepinephrine 
accU!Ilulated into the tissue . In reserpinized hearts, how-
ever, the amount of norepinephrine in the perfusate was the 
same as in the perfusate of normal hearts, but tissue anal-
ysis revealed very much lower levels of catecholamine ·;i i th 
very high levels of MAO metabolites in the perfusate . These 
These results suggested that norepinephrine accumulation was 
1 1 
not affected but its subsequent storage was. 
Iversen (1965a, 1965b) reported characteristics of the 
uptake of norepinephrine into isolated rat hearts. At low 
concentrations of epinephrine or norepinephrine (.07 - 7 uM) 
the uptake followed classical Michaelis-Menten kinetics and 
Km and Vmax values where calculated showing a greater 
affinity of the stereoisomer, 1-norepinephrine, for the 
uptake mechanism than d-norepinephrine. The racemate, 
dl-norepinephrine, exhibited a higher Vmax and lower Km 
than dl-epinephrine. 
Similar experiments were performed using high concen-
trations of catecholamines (5-230 uM) in the perfusion 
medium (Iversen 1965a, 1965b). The accumulation of catech-
olamines under these conditions could not be explained in 
terms of the uptake system described when using low catechol-
amine concentrations in the perfusate, however, the char-
acteristics of this uptake process could be described using 
classical enzyme kinetic models. This second uptake system, 
a process for which the term Uptake 2 (u2 ) has been applied, 
showed a much lower affinity than could be ascribed to the 
initial uptake system described (referred to as Uptake 1, 
abbreviated u1 ). 
Several properties of u2 serve to distinguish it from 
u1 • Catecholamines accumulated by u2 disappeared rapidly 
from the tissue if the perfusion was continued using a 
catecholamine-free medium, although 2 ug. of catecholamine 
per gram of tissue remained even after prolonged periods of 
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washout. A comparison of the kinetic constants showed that 
unlike u1 , u2 exhibited no stereospecificity; also, although 
u2 accumulated norepinephrine more rapidly, epinephrine 
exhibited a greater affinity for uptake with the Km being 
about five times lower than that for norepinephrine. 
Although u2 appeared inoperative at low substrate concen-
trations and thought to be activated where a critical thresh-
old of substrate concentration is reached (Iversen, 1965a), 
a more recent study reported evidence to conclude that both 
systems operate at all substrate concentrations with u1 
having the greater influence at low and u2 at high substrate 
concentrations (Lightman and Iversen, 1969). 
Another property serving to distinguish between u1 and 
u2 includes substrate specificity and the effect of drugs 
on inhibiting the transport effected by each system. Burgen 
and Iversen (1965) reported the results of a variety of 
substituted B-phenylethylamines on the u2 system. Interest-
ingly, 0-methylation as well as N- substitution greatly 
enhanced that affinity for u2 ; whereas the effect of these 
compounds on u1 are exactly opposite in nature (Horn, 1973). 
Cocaine, imipramine and desipramine while potent inhibitors 
of u1 were found to be only weakly active with respect to 
u2 (Iversen 1965a; Salt, 1972). Phenoxybenzamine is a 
potent inhibitor of u2 as is a variety of steroids including 
B-estradiol, corticosterone, testerone, deoxycorticosterone 
and androsterone (Iversen and Salt, 1972). 
Originally it was suggested that u2 might represent a 
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sepqrate neuronal membrane transport system at sites along 
the entire neuron; that is, cell body, axon and nerve 
terminal. Evidence for this concept was provided by the 
histochemical studies of Norbert and Hamberger (1964) and 
Hamberger et al. (1964) who reported that the accumulation 
of norepinephrine was localized to terminal regions of post-
ganglionic sympathetic neurons when low doses of norepin-
ephrine were administered and amine throughout the cell 
body and axon as well as the terminals when high doses were 
administered. This hypothesis, however failed to explain 
the washout phenomenon reported to exist for u2• 
Another possibility offered was that u2 may represent 
an uptake of catecholamines by storage granules within 
adrenergic neuronal terminals (Iversen, 1965a). Evidence 
for this hypothesis included the indisputable similarity of 
properties between u2 and eith er isolated adren ergic nerve 
granules or adrenal medullary granules incubated in-vitro 
(Euler and Lishajko, 1964; Carlsson et al., 1963). The 
particle uptake system is saturable at amine concentrations 
of 80 ug/ml. which is very close to that described for u2 , 
also, both are relatively insensitive to inhibition by 
cocaine, desipramine or metraminol and both are inhibited by 
tyramine and pk enoxybenzamine. Granular uptake lacks 
specificity for the optical isomers of epinephrine and nor-
epinephrine. Finally, the uptake of catecholamines in 
isolated granules occurs at concentrations of 1 ug/ml. or 
higher in the absence of magnesium and adenosine triphos-
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phate and u2 is known to begin to exert substantial influence 
at this concentration of amine. One important difference 
between u2 and the isolated particles is reflected by the 
fact that no difference in affinity can be shown for 
epinephrine and norepinephrine as can be observed in the u2 
system. 
The hypothesis which has gathered the most support by 
far is that u2 represents an extra-neuronal uptake mechanism 
(Iversen, 1975). Support has come from the results of 
histochemical studies of the distribution of catecholamines 
in various tissues after exposure to high concentrations 
of exogenously administered norepinephrine. The work of 
Fisher and Kopin (1964) cited earlier may have provided 
that needed impetus to investigate the association between 
non-neuronal or extra-neuronal uptake and u2• After per-
fusion of rat hearts with medium containing high concentra-
tions of norepinephrine, intense flourescence was observed 
in cardiac muscle cells and unidentified connective tissue 
cells as well as nerve terminals (Ehinger and Sporrong, 
1968; Farnebo and Maimfors, 1969; Clarke et al., 1969; 
Jacobowitz and Brus, 1971). Extraneuronal uptake, like u2 , 
was found to be sensitive to normetanephrine and relatively 
insentive to desimpramine (Farnebo and Malfors, 1969; Clarke 
et al., 1969). Numerous reports of uptake of catecholamines 
into nonneuronal tissue including salivary gland parenchyma 
(Hamberger, 1967), smooth muscle of cat spleen (Gillespie 
1968, 1973), vas deferens (Gillespie et al., 1970), chick 
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amnion (Burnstock et al., 1971), perfused rabbit ear artery 
(Avakian and Gillespie, 1968), cat nictitating membrane 
(Draskoczy and Trendlenburg , 1970) and guinea pig trachea 
(O'Donnell and Saar, 1973), appeared. Kinetic constants for 
the extra-neuronal uptake into arterial cells was shown to 
have characteristics similar to u2 (Gillespie and Towart, 
1973). The uptake of norepinephrine into smooth muscle 
also showed susceptibility to phenoxybenzamine and washout 
was inhibited by normetanephrine (Gillespie, 1968). 
Although u1 has been considered the principal mechanism 
responsible for the inactivation of physiological concentra-
tions of norepinephrine (Iversen, 1971), the preponderance 
of sympathetic innervation is clearly a consideration in 
determining the importance of either uptake mechanism in 
isolated tissue preparations, as is the concentration of 
catecholamine in the medium. Smooth muscle of the vas-
culature contains relatively little sympathetic innervation 
and it would seem reasonable to conclude that u2 is most 
important in terminating the action of circulating catechol-
amines in this tissue. The evidence to support the 
hypothesis that neuronal uptake isthe principal inactivating 
mechanism of depolarize-released neurotransmitter comes 
from reports that organ response to sympathetic nerve stim-
ulation is greatly increased by drugs shown to be effective 
inhibitors of the neuronal uptake mechanism (Thoenen, 1964a, 
1964b; Brown , 1965). Based on results reported by Langer 
(1970), u1 may account for the recapture of as much as 70-
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90% of the transmitter released by low frequency sympathetic 
nerve stimulation in the cat nictitating membrane. 
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B. Characterization of kinetically distinct neuronal uptake 
mechanisms. 
i) Norepinephrine, dopamine and tyrosine: 
Norepinephrine uptake as an active process described 
using Michaelis-Menten kinetics was dissociated from the 
contribution of passive diffusion by using low substrate 
concentrations (l0-7M) in the medium of brain slice prepara-
tions (Dengler, 1962). The active component of uptake into 
brain slices was shown to be temperature dependent, occur 
against a concentration gradient, be dependent upon Na+ in 
the medium, require oxygen and glucose, can be lowered by 
metabolic inhibitors (Dengler et al., 1962; Dengler, 1965; 
Ross and Renyi, 1964, 1966), and does not require calcium 
or magnesium ions (Hamberger, 1967). Limited accumulation 
occurs when incubation is carried out in a sucrose medium 
(Mirkin et al., 1963). 
Similar results have been reported with the use of a 
crude _synaptosomal homogenate. Davis et al. (1967), 
Bogdanski and Tissari (1967), Bogdanski et al. (1968) 
Colburn et al. (1968) and White and Keen (1971) all showed 
an absolute requirement for 143 mM Na+ concentrations and 
inhibitory effects of increasing K+ concentrations above 
5mM, as well as temperature dependence and reduction in 
uptake by metabolic inhibitors. Conclusions of these 
studies suggest that uptake by brain slices, at low sub-
strate concentrations similar to that used by Dengler (1962), 
occurs primarily into neuronal endings. 
Harris and Baldessarini (1973) showed similar require-
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ments for dopamine uptake into rat corpus striatum with one 
notable exception. Whereas Snyder and Coyle (1969) reported 
no substantial effect on initial uptake of catecholamines 
using reserpine pretreatment, Harris and Ealdessarini (1973) 
reported a considerable effect. 
Additional support for the hypothesis that amine accu-
mulation occurs into nerve endings comes from the work of 
Snyder et al. (1965) who showed that intraventricular 
injection of labeled norepinephrine was found localized to 
a great extent in the synaptosomal fraction upon differ-
ential centrifugation. Histochemical techniques confirmed 
that the uptake of monoamines into rat cerebral cortex was 
confined to varicosities indistinguishable from those con-
taining endogenous norepinephrine (Eamberger and Masuoka, 
1965; Hamberger, 1967). Eenn (1967) using electron micro-
scopic autoradiography reported that 80% of the H3-nor-
epinephrine accumulated by brain slices was localized to 
neurons. More recently Lidbrink and Jonsson (1974) showed 
a reduction of uptake of norepinephrine into cerebral 
cortices after noradrenergic terminals were destroyed by 
lesion of the dorsomedial reticular formation with 6-hydroxy-
dopamine. 
Snyder and Coyle (1969) studied the stereospecificity 
of norepinephrine and dopamine uptake in different areas of 
the rat brain. The Michaelis constant of 0.4 uM for nor-
epinephrine uptake into extrastriatal areas is in good 
agreement with the 0.56 uM Km reported by Colburn et al. 
19 
(1968) using whole rat brain. Snyder and Coyle (1969) 
extended the range of catecholamine concentration from 0.05 
uM using 1.2 uM as the upper limit. They reported that the 
striatum had a higher affinity for dopamine than norepin-
ephrine and both neurotransmitters display only a single 
uptake component over the ra.~ge of substrate concentrations 
studied. All other brain areas showed two components of 
dopamine uptake, one considered a high affinity the other a 
low-affinity transport mechanism, whereas norepinephrine 
continued to be described adequately by a straight line 
using the Lineweaver-Burk method suggesting only one trans-
port system exists for this amine. In a later paper (Coyle 
and Snyder, 1969), they reported the Ki values for mutual 
inhibition of dopamine and norepinephrine uptake in all 
regions of rat brain to be identical with their respective 
Km values and concluded that these two catecholamines use 
the same transport systems (presumably dopaminergic) and 
would not require such a characteristic. 
The uptake of precursors of norepinephri:ooand dopamine, 
namely tyrosine and dopa, have been described (Naeme, 1961; 
Guroff et al., 1961; Dengler et al., 1962; Yoshida et al., 
1963a, 1963b, 1963c, 1965) but delineation of two transport 
systems has not been the focus of attention and wheth er 
these systems exist remains to be sh own. Chirigos et al., 
(1960) have reported stereospecificity of 1-tyrosine for 
brain tissue and illustrated its uptake inhibition by the 
amino acids leucine, isoleucine, valine, histadine and 
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cysteine. They also noted that stereospecificity was 
lacking in muscle preparations. Interestingly, Ross and 
Renyi (1966) studied the uptake of tyramineand 1-dopa at 
concentrations similar to those reported for high affinity 
uptake of dopamine (Snyder and Coyle, 1969) and reported 
Km's for dopamine and tyrosine of 0.7 uM and 0.4 uM, 
respectively, in slices of whole brain. These values are 
similar to those reported for extra-striatal norepinephrine 
uptake (Coyle and Snyder, 1969; Snyder and Coyle, 1969). It 
would appear that these Km values adequately describe a 
high affinity component of uptake when compared with other 
amino acids with Km's in the millimolar range (Cohen and 
Lajtha, 1972). In addition, Wofsey et al. (1971) present 
evidence to indicate that tyrosine may become selectively 
incorporated into a population of synaptosomes that can be 
separated from those which accumulate norepinephrine by a 
technique known as incomplete equilibrium centrifugation. 
ii) Seroton"in and tryptophan: 
Fuxe and Ungerstedt (1967) described the localization 
of intraventricularly administered serotonin to serotonergic 
neurons using histochemical flourescence techniques. 
Although a number of attempts were made to illustrate 
serotonin accumulation in brain slices (for a review see 
Katz and Chase, 1970) most attempts were unsucessful in 
separating out an active transport process fro.m simple dif-
fusion until Blackburn et al. (1967) incubated brain slices 
with c14-serotonin at a concentration of 2xl0-8M and 
21 
reporte~ considerable accumulation of the amine with 60Yo 
recovered in the synaptosomal fraction upon subcellular 
fractionation using differential centrifugation techniques. 
Similarly, Kuhar et al. (1970) studied the subcellular 
localization of serotonin after incubation of brain slices 
with the amine in concentrations ranging from 10- 5 to 10-8 M 
and found the major portion of accumulated serotonin local-
ized to synaptosomes. 
The kinetics of serotonin accumulation into slices of 
rat striatum and hypothalamus revealed two distinct trans-
port processes with KmH=l.7xl0-7M and Km1=8 .0xl0-
6M in t he 
-7 - 6 
striatum and KmH=l.4xlO M and Km1=8.0xl0 M in the hypo-
thalamus (Shaskan and Snyder, 1970). The Ki values for t h e 
competitive inhibition of norepinephrine uptake by serotonin 
approximated the Km for low affinity serotonin into catechol-
aminergic neurons. These kinetically distinct components 
were confirmed by Wong et al. (1973). 
Kuhar et al. (1974) review the results of a number of 
studies illustrating the reduction of serotonin uptake 
associated with the selective destruction of serotonin nerve 
terminals by midbrain raphe lesions suggesting that uptake 
occurs predominantly into serotonergic nerve endings when 
low substrate concentrations are employed. Histochemical 
flourescence as well as the measurement of tryptophan 
hydroxYlase activity and endogenous serotonin levels support 
the hypothesis that high affinity uptake process is specific 
for neurotransmitter inactivation upon depolarized release 
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(Kuhar et al., 1972). Massari and Sanders-Bush (1975) have 
utilized this concept of high-affinity neurotra.nsmitter-
specific uptake to compare the effects of para-choloro-
amphetamine or B-9 lesions with the distribution of seroton-
ergic neuronal endings in different areas of the brain. 
Initial studies of tryptophan transport into synapto-
somal preparations utilized substrate concentrations limited 
to the low affinity component of transport (Grahame-Smith 
and Farfitt , 1970). In this study the concentrations of 
sodium ions in the media were varied from 0 to 112 mM by 
osmotic replacement with either choline or sucrose and 
resulted in no effect on tryptophan uptake, however, cyanide 
and ouabain did significantly reduce the uptake of substrate. 
Interestingly, preloading the synaptosomes with 1-tryptophan 
resulted in an increase in the uptake of either 1-tryptophan 
or 1-phenylalanine. L-Tryptophan preloaded synaptosomes 
were also sho~n to greatly accelerate the rate of efflux of 
tryptophan by either 1-tryptophan or 1-phenylaJanineimplying 
that a faciltated exchange process was occuring. A number 
of amino acids were reported very active in stimulating the 
efflux of tryptophan from preloaded synaptosomes. It would 
appear that this low affinity transport system represents 
the same mechanism by which other amino acids gain entry 
into the neuron and is not specific for tryptophan. 
A more recent study revealed a high affinity component 
of the uptake of 1-tryptophan as well as a low affinity 
component (Parfitt and Grahame-Smith, 1974). Alth ough the 
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affinity Michaelis constant (KmL) originally reported by 
Grahame and Parfitt (1970) as l.Oxl0- 3M is considerably 
disparate from their more recent data ( KmL 3.2xl0-4M); use 
of different tissue preparation, i.e. whole brain vs. 
cerebral cortex, can account for the results. The KmH, 
however, is only lower than the the KmL by a factor of 
three reported in this study, (Parfitt & Grahme-Smith, 1974), 
whereas, other investigators have reported differences 
between high and low affinity uptake systems differing from 
a minimum of 21 (in cerebral cortex) to over 300 (glycine in 
the spinal cord) orders of magnitude which would appear to 
represent physiologically more distinguishable processes 
(Snyder et al., 1973). 
iii) Other neurohumors: 
a) Acetylcholine and choline: 
Unlike the catecholamines and serotonin, acetylcholine 
appears to be inactivated largely by the intrasynaptic 
degradative enzyme acetylcholinesterase and diffusion rath er 
than an uptake mechanism (for a review see Katz and .1 iledi, 
1973). Early work aimed at characterizing an uptake process 
for acetylcholine did not prove fruitful (Guth, 1962; 
Burton, 1964). Even in the presence of the reversible chol-
inesterase inhibitor physostigmine, negative results were 
reported (Elliot and Henderson, 1951; Schuberth and Sundwall, 
1967) although it was suggested that physostigmine may have 
strong inhibitory actions on the uptake mechanisms (Polak 
and Meeuws, 1966). Use of the organophosphate cholinester-. 
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ase inhibitors including paraoxon (Diethyl-4-nitrophenyl 
phosphate) have resulted in significant accumulations of 
acetylcholine into brain tissue (Polak and Meeuws, 1966; 
Schuberth and Sundwall, 1967; Liang and Quastel 1969; 
Heilbronn, 1969) with the uptake requirement for oxygen, 
reduced by metabolic inhibitors and described using 
Michaelis-Menten kinetics (Schuberth and Sundwall, 1967; 
Polak and Meeuws, 1966; Liang and Quastel, 1969). 
Acetylcholine uptake seems unimportant physiologically 
for it has been shown that acetylcholine uptake into synapt-
osomes is neither readily incorporated into vesicles 
( Marchbanks, 1968) nor released by electrical stimulation or 
potassium depolarization (Katz et al., 1973). Further 
evidence leading to a conclusion that acetylcholine uptake 
is not physiologically important comes from the results of 
Marchbanks (1969b) and Adamic (1970) suggesting that both 
molecules utilize the same carrier. Similarly autoradio-
graphic techniques have been employed using slices of rat 
cortex incubated in labeled acetylcholine and the distri-
bution of label w~s reported as diffuse with no obvious 
preference for specific cell types or structures (Polak, 
1969). Finally, Katz et al. (1973) attempted to collect t he 
excess acetylcholine which might be produced by brain 
stimulation in the presence of an acetylcholine uptake 
inhibitor if the acetylcholine transport process were phys-
iologically active. They report that no additional acetyl-
choline is collected in the presence of uptake inhibitor 
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and conclude that acetylcholine uptake may not be physio-
logically operational. These results may be explained by 
considering the transport mechanism responsible for acetyl-
choline uptake to be identical with the choline carrier; 
the low affinity choline transport mechanism being common 
to all cells requiring choline as substrate for synthesis 
of phasphatidyl- or phosphorycholine. 
Hodgkin and Martin (1965) first described the ability 
of choline to be transported into excitable .tissue, the 
squid axon. A year later Schuberth et al. (1966) reported 
the presence of choline in cerebral cortex tissue slices 
and localization of choline transport within nerve endings 
was established by Marchbanks (1968b) using synaptosomal 
preparations with a reported Km of lOOuM. A number of 
similar studies reported Km's varying from as low as 80 uM 
(Potter, 1968) to 440 uM (Hensworth and Bosmann, 1971). 
Green and Haubrich (1971) using synaptosomal prepara-
tions incubated with low concentrations of choline, reported 
a significant amount of acetylcholine formed and suggested 
that more than one uptake system may exist for choline 
accumulation in the brain. Yamamura and Snyder (1973) and 
Dowdall and Simon (1973) reported two kinetically distinct 
carrier-mediated systems for choline transport having a K~ 
of 1-5 uM and KmL less than 25 uM. The two systems showed 
clearly distinguishable effects of Na concentration (Haga 
and Noda, 1973) with the high affinity component more dep-
endent on alterations in sodium concentration in the media. 
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Although it has been suggested that the high affinity 
component represents a mechanism of cholinergic neurons 
which may serve to recapture the product of intrasynaptic 
acetylcholinesterase for the synthesis, storage and sub-
sequent reutilization of acetylcholine, conclusive evidence 
of this is not available as yet (Kuhar and Murrin, 1978). 
Kuhar , et al. (1973) have provided evidence to indicate 
that choline uptake occurs into cholinergic neurons primar-
ily by the high affinity uptake process. Septal lesions, 
known to result in reductions of acetylcholine in the 
cerebral cortex and hippocampus, resulted in a reduction of 
choline uptake by 6alo in synaptosomes prepared from these 
cholinergically innervated areas, whereas, tryptophan and 
glutamatic acid accumulation were unaffected although GABA 
and norepinephrine uptake were affected slightly. 
b) gamma-Aminobutyric acid (GABA) 
GABA was shown to be taken up by slices of rat cerebral 
cortices when a low concentration (0.05uM) of substrate was 
used in the medium (Iversen and Neal , 1963). The electron 
microscopic autoradiographic experiments of Bloom and 
Iversen (1971) suggest that more than 7cY~ of the GABA 
taken up into brain slices is localized to the nerve term-
inals. It has also been suggested that at this low concen-
tration, reminiscent of that used to detect high affinity 
uptake, a distinct population of nerve terminals are res-
ponsible for the uptake of labeled GABA (Iversen and Snyder, 
1968; Iversen and Johnston, 1971). Clearly distinguishable 
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high and low affinity components for GABA uptake into 
synaptosomes and brain slices have been reported (Levi and 
Raiteri, 1973a, 1973b). 
As with other high affinity transport systems there is 
an absolute requirement for physiological concentrations of 
electrolytes and uptake is inhibited strongly by low con-
centrations of Na+ (Iversen and Neal, 1968). Inhibition of 
GABA uptake has been reported with 2,4-dinitrophenol, oua-
bain and malonate (Kuriyama et al., 1969; Snodgrass et al., 
1973). 
c) Glutamate, aspartate and glycine: 
Logan and Snyder (1972), Balcar and Johnston (1972a, 
1972b) and Bennett et al. (1972) have studied the uptake of 
glutamate and aspartate and have reported that transport 
occurs by both high and low affinity mechanisms with the 
high affinity system having an absolute dependence on 
sodium ions. Furthermore, the metabolic requirements of 
both glutamate and aspartate uptake are indistinguishable 
with azide, eyanide and omission of glucose from the media 
having minimal effects and it appears as though glutamate 
and aspartate share the same transport carrier. Wofsey 
et al. (1971), using subcellular distribution studies, have 
associated the high affinity uptake with a unique popula-
tion of nerve terminals suggesting that the high affinity 
mechanism may be directly related to the function of 
replenishment of neurotransmitter. 
A high affinity uptake system specific for glycine has 
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been shown in slices of rat spinal cord, pons and medulla 
( Neal, 1971; Jolmston and Iversen, 1971), slices of cat 
spinal cord (Balcar and Johnston, 1973) as well as in crude 
synaptosomes of rat spinal cord (Logan and Snyder, 1972; 
Bennett et al., 1972) and in purified synaptosomes of 
cerebral cortex of the rat (Peterson and Raghupathy, 1973). 
Localization of glycine uptake into nerve endings by the 
high affinity system has been shown by autoradiographic 
analysis ( ~atus and Dennison, 1972; Iversen and Bloom, 1972; 
Ehinger, 1972; Hosli and Hosli, 1972; Ljungadhl and Hokfelt, 
1973) as well as subcellular fractionation teclmiques 
(Johnston and Iversen, 1971; Arregui et al., 1972). 
Glick (1972) has shown inhibitors of Na+/K+ dependent 
ATP-ase to be effective inhibitors of glycine uptake; how-
ever, no inhibitors has yet been described as being more 
effective in inhibiting either the high or the low affinity 
uptake. The low affinity mechanism of glycine uptake seems 
to be relatively no~-specific in that 1-alanine,l-serine 
and other small neutral a,~ino acids compete for the trans-
port site (Cohen and Lajtha, 1972). 
d) Histamine and histadine: 
Although the probable mechanism of histamine inactiva-
tion is via the degradative enzyme histamine methyltrans-
ferase, subcellular distribution studies show the incorpor-
ation into the P2 (synaptosomal) fractions and after sub-
sequent treatment in a hypo-osmotic medium histamine was 
shown to be localized to the vesic11lar fraction (Snyder 
2~ 
et al., 1974). Young et al. (1971) reported an ontogenic 
related change in the distribution of histamine among sub-
cellular fractions. Older animals (21 days) showed greatest 
accumulation in the synaptosomal fraction whereas younger 
animals appeared to concentrate histamine in the nuclear 
pellet. 
A stereospecific uptake of L-histidine into brain slices 
has been demonstrated (Neame, 1964) although the substrate 
concentrations were not low enough to differentiate a high 
affinity component and in all probability the low affinity 
system is shared by other basic amino acids such as trypto-
phan. 
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c. Effects of tricyclic antidepressants on the hi-affinity 
uptake process of serotonergic noradrenergic and 
dopaminergic neurons. 
i) in-vitro 
The ability of tricyclic antidepressants to block the 
uptake of norepinephrine into brain slices was described 
by Dengler et al. (1961) using concentrations of radio-
actively labeled norepinephrine (2.8 - 14.0xl0-8M) well 
within the concentration range where hi-affinity transport 
is responsible for a large part of the uptake of nor~pin­
ephrine into nerve endings. The concentration at which the 
uptake of norepinephrine into nerve endings is inhibited by 
fifty percent, (rc50 ), varies depending upon the prepara-
tion used, i.e. brain slices versus synaptosomes, as well 
as by brain region. The rc50 for desmethylimipramine (DMI) 
varies from 0.003 uM in rat brain synaptosomes (Ross and 
Renyi, 1975a) to 0.11 uM in rat brain slices (Salama et al., 
1971). Buus Lassen et al., (1975) reported an 1c50 for DMI 
of 10 uM in rat forebrain synaptosomes as opposed to 0.001 
uM in synaptosomes prepared from rat hippocampal tissue. 
The large difference is believed to be due to the concentra-
tion of noradrenergic neuronal endings within brain regions 
(Squires, 1974; Buus Lassen et al., 1975). 
It is also true that studies utilizing different spe-
cies as well as different preparations reported identical 
rc50 values for the tricyclics tested. Ross and Renyi 
(1967a) utilizing mouse cortex slices reported an 1c50 
value of 0.03 uM for the inhibition of norepinephrine uptake 
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by DNI whereas an identical value was reported by Shaskan 
and Snyder (1970) using a crude synaptosomal homogenate of 
rat hypothalamus. A good correlation between the partition 
coefficient and the Ic50 values for a number of chemically 
different uptake inhibitors was found to exist in brain 
slices (Carmichael and Israel, 1973). 
All studies report DMI to be the most potent tricyclic 
tested with respect to its ability to block norepinephrine 
uptake (Ross and Renyi, 1967a; Shaskan and Snyder, 1970; 
Horn et al., 1971; Salama et al., 1971; Carmichael and 
Israel, 1973; Squires, 1974; Maxwell et al., 1974; Ross and 
Renyi, 1975a; Buus Lassen et al., 1975). Many studies 
indicate that the demethylated form of the tertiary amines, 
i.e. the secondary amines, are more potent with respect to 
their ability to inhibit norepinephrine uptake whereas the 
tertiary amines are more efficacious in its effect on sero-
tonin uptake (Blackburn et al., 1967; Ross and Renyi 1967b; 
1969; Carlsson, 1970; Shaskan and Snyder, 1970; 
Kannengiesser et al., 1973; Horn and Trace, 1974; Ross and 
Renyi, 1975a and Buus and Lassen et al., 1975). 
Structure activity relationships have been studied 
with respect to both the noradrenergic (Horn and Snyder, 
1972; Ferris et al., 1972; Horn, 1973a; Maxwell et al., 
1974) and serotonergic (Horn, 1973b) transport system in the 
central nervous system. It is on the basis of these studies 
that evidence can be found to substantiate the concept that 
there exists a chemically distinguishable transport 
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mechanism for each neurotransmitter. 
The uptake inhibitory characteristics of tricyclics as 
they apply to dopamine have been studied (Ross and Renyi, 
1967a). Their effect on this transport system has not 
generally been considered as important due to the relatively 
large 1c50 values reported (Horn et al., 1971). There is 
no correlation with the inhibition of uptake of dopamine 
into either rat hypothalamus or whole brain synaptosomes 
with respect to methyl substitution on the side chain nitro-
gen of any of the tricyclic antidepressants (Horn et al., 
1971; Halaris et al., 1975). Alternatively, antiparkin-
sonian drugs have been shown to be very potent in their 
ability to block dopamine uptake in the central nervous 
system (Coyle and Snyder, 1969b). 
ii) in-vivo 
Imipramine was shown to reduce the amount of labeled 
epinephrine found in homogenates of whole mice when compared 
with saline treated controls (Axelrod and Tomchick, 1959). 
Similarly, imipramine increased the rate of disappearance of 
labeled norepinephrine in the whole animal (Axelrod and 
Tomchick, 1960). Hertting et al. (1961) reported reduced 
levels of H3-norepinephrine in heart, spleen, adrenals, 
liver and muscles with elevated normetanephrine found in 
muscle tissue after treatment with imipramine. Glowinski 
and Axelrod (1964) administered imipramine DMI or amitripty-
line to rats and after 1 hour administered H3-norepinephrine 
by an intra-cerebroventricular (ICV) injection. All three 
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compounds were reported to be effective in inhibiting the 
uptake of H3-NE into rat brain. It is interesting to note 
that Schanberg (1963) could not show imipramine to be 
effective in inhibiting the uptake of 5-hydroxytrptophan, 
the precursor of serotonin, into brain slices when the drug 
was administered i.p. 1 hour prior to sacrifice with sub-
sequent testing in-vitro. 
As with the in-vitro data, many studies measuring the 
effectiveness of tricyclics on either norepinephrine or 
serotonin uptake report tertiary amines as being more 
effective then the secondary amines in blocking the uptake 
of 5HT in the central nervous system (Ross and Renyi, 1975b). 
Conversely, a number of studies conclude the secondary 
amines to be more effective than tertiary amines in blocking 
NE uptake (Ross and Renyi, 1967; Schildkraut et al., 1969a; 
Carlsson et al., . 1969b; Ross and Renyi, 1975b). 
Palaic et al., (1967) reported no uptake inhibitory 
effect of DMI lOmg/kg; injected i.p. 20 minutes prior to ICV 
H3-5-HT injection. Similarly, Carlsson (1970) could not show 
an effect of DMI on the release of serotonin by H75/12 into 
rat brain. Schubert et al., (1970) failed to demonstrate 
an effect on the rate of disappearance of H3-5-HT after 
intravenous injection of H3-tryptophan of either secondary 
amine, DMI or nortriptyline, whereas both imipramine and 
amitriptyline retarded the rate of disappearance of H3-5-HT. 
Histochemical evidence is available to suggest that imip-
ramine blocks serotonin uptake (Carlsson et al., 1968; 
Corrodi and Fuxe, 1968). 
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D. Effects of tricyclics on t he metabolism of biogenic 
amines: 
i) Serotonin 
Da Prada and Pletscher (1966) reported a significant 
reduction in the levels of 5-hydroxyindoleacetic acid, 
(5-HIAA) the major metaboliteof serotonin in the CNS, for 
both imipramine and amitriptyline. The ratio of product to 
precursor indicates that imipramine is slightly more effi-
cacious in reducing the turnover of serotonin and this is 
reflected in the in-vitro data as well (Ross and Renyi, 
1969; 1975; Kannengiesser, 1973). Palaic et al., (1967), 
using an intracerebroventricular perfusion of H3-5HT at 
55 uM concentration for 1 hour, demonstrated a reduction in 
endogenous levels of 5-HIAA but not of H3-5EIAA. At this 
concentration the predominant idoleamine inactivation 
mechanism is presumably a low affinity transport system. 
It seems possible that the effect of DMI on inhibiting the 
uptake of 5HT may have been overshadowed by the low affinity 
transport mechanism as well as diffusion. A reduction in 
endogenous levels of 5HIAA imply decreased activity of the 
neuron which may come about as a result of feedback mech-
anisms in the event DMI is inhibiting 5HT uptake. Sub-
sequently increases in the intrasynaptic amine concentration 
and hence its interaction with post-synaptic receptors is 
the postulated mechanism for feedback inhibition (Costa and 
Meek, 1974). 
c14-serotonin was administered intracisternally 15 
minutes prior to an i.p. injection of either DMI or I MI 
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(25mg/kg) and 2 hours after the intracisternal injection 
brains were assayed for H3-5HT and deaminated metabolites 
(Schildkraut et al., 1969b). The results indicate imipr-
amine as being more effective in increasing levels of 
radioactive amine. These results are consistentwith the 
idea that the tricyclics reduce the turnover of '5HT by the 
postulated inhibitory feedback mechanism. Similar results 
were obtained in the study of Schubert et al., (1970) in 
which both imipramine and amitriptyline reduced the turn-
over of 5HT as measured by a reduction in the ratio of H3-
tryptophan to H3-5HT . Bruinvels (1972) and Alpers and 
Himwich (1972) reported reduced turnover of 5HT as a result 
of tricyclic treatment. More recently, Leonard and Kafoe 
(1976) showed a decreased turnover of serotonin with both 
acute and chronic imipramine as well as DMI treatments. 
Buus Lassen et al., (1975) tested the effects of tricyclics 
administered 3 hours prior to sacrifice and all resulted in 
lowering levels of 5HIAA. 
ii) Norepinephrine 
Schanberg et al., (1967) administered either I MI or 
DMI 90 minutes prior to the intraventricular administration 
of H3- NE and demonstrated increased levels of H3-normeta-
nephrine in the brains of drug treated rats. When the 
drugs were given 90 minutes after the intraventricular 
injection of H3-NE and animals were sacrificed 3 hours 
after the antidepressant, the levels of labeled norepin-
ephrine increased. Norrnetanephrine increased and deaminated 
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catechol metabolites decreased reflecting the anticipated 
response of agents which block the uptake mechanism. 
Schildkraut et al. (1969a) demonstrated greater decreases 
in levels of H3-NE by treatment with secondary amines DMI 
and PRO than by the tertiary amines I MI and AMI. In fact 
AMI did not result in altering the levels of H3-NE found in 
the brains of drug treated rats when compared with saline 
treated controls. These results are similarly reflected in 
the in-vitro data of Ross and Renyi (1967a) and Shaskan and 
Snyder (1970). Schildkraut et al. studied the effects of 
chronic administration of the tertiary amine, imipramine 
(1970), and the secondary amine protriptyline (1971), on the 
levels of norepinephrine and its metabolites. In these 
experiments, tricyclic antidepressants were administered 
by intra-peritoneal injection and H3-NE followed 6 hours 
later by intracisternal injection. The animals were sacri-
ficed either 6 minutes or 3 1/2 hours after the labeled 
compound was administered. Upon acute administration, 
imipramine significantly reduced the levels of H3-NE when 
animals were sacrificed 6 minutes after the label whereas 
the reduction by protriptyline was not statistically signif-
icant. Normetanephrine levels were increased whereas 
deaminated catechols and 0-methylated deaminated metabolites 
were decreased for both drugs studied. When the animals 
were sacrificed 3 1/2 hours after the label was administered, 
a trend towards increased values of norepinephrine was noted 
but did not achieve statistical significance. These 
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results could be explained within the framework of the 
proposed mechanism of action of these drugs as transport 
inhibitors. It seems reasonable that after 9 1/2 hours 
the drug was nearly completely metabolized and the neurons 
responded to the effect of decreased levels in the presence 
of drug to increasing their levels by facilitating the 
uptake of amines. Normetanephrine levels remained somewhat 
elevated and deaminated catechol metabolites were not nearly 
as depressed as after the 6 minute sacrifice period. Chronic 
administration of either drug resulted in decreased levels 
of H3-norepinephrine when studied either 6 minutes or 3 1/2 
hours after administration of the labeled amine. Similarly, 
normetanephrine was increased and deaminated catechol met-
abolites were severelydepressed. The levels of endogenous 
amines were reduced below control f or both drugs. The data 
suggests that both the secondary and tertiary amines have 
the same effect on norepinephrine metabolism when admin-
istered chronically; that of inhibiting uptake and increasing 
turnover as measured by the rate of disappearance of H3- NE 
from the brain (levels of H3- NE at 6 minutes vs. levels at 
3 1/2 hours after label). 
In a more recent study of the effect of chronic admin-
istration of DU and Dl\1I, turnover of the biogenic amines 
including norepinephrine was reported as being decreased 
although the decrease was not statistically significant 
(Leonard and Kafoe, 1976). In these experiments turnover 
was measured as the ratio of specific activity of labeled 
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product to labeled precursor after administration of H3-
tyrosine and H3-tryptophan. The results are obviously at 
variance with that reported by Schildkraut et al. (1970, 
1971) with respect to the turnover of norepinephrine, and 
the authors could not offer a reason for the apparant 
discrepancy. The effects of chronic administration of 
tricyclics on the turnover of norepinephrine awaits further 
study before a conclusion can be drawn. 
iii) Dopamine 
Dopamine has been the least studied of the catechol-
amines with respect to the effects of tricyclic anti-
depressants on its metabolism. Da Prada and Pletscher (1966) 
reported a slight but insignificant decrease of homovanillic 
acid (HVA) after an acute administration of imipramine 
whereas amitriptyline caused a significant increase in HVA. 
Similar results were obtained by Nielsen (1975) in a study 
of the affect of acutely administered amitriptyline. Levels 
of dopamine were shown to be increased although the increase 
did not achieve statistical significance. DMI, however, 
did increase the levels of dopamine significantly. 
Chronic administration of both imipramine and DMI 
decreased the turnover of dopamine (Leonard and Kafoe, 1976). 
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CHAPTER III: EXPERIMENTAL WORK 
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A. Introduction: 
The use of any experimental system necessitates an 
evaluation of its performance characteristics or· character-
ization. The rigor applied to characterization is often 
goverened by the investigators lrn.owledge and understanding 
of the system as acquired through a review of the literature 
and personal experience. In this regard, the following 
characterization experiments were performed to establish 
some of the important parameters pertinent to the experi-
mental protocol as well as some characteristics believed to 
be indicative of a properly functioning system. 
Following the characterization are experiments designed 
to directly test the hypothesis that protriptyline blocks 
the uptake of tritiated 1-norepinephrine in an in-vitro 
hypothalamic synaptosomal test after acute, subacute and 
chronic administration of the drug. Since the methodology 
employed in the characterization differs little with that 
used for the test of the hypotheses, the methods section 
contains a "general methods" section and the deviations 
from the general methods are noted in the subsequent num-
bered subsections corresponding to each individual experi-
ment. 
Subsection i through ix can be considered character-
ization experiments and x through xii are specifically 
directed towards the objective of this thesis. 
B. Methods: 
General: Male Long Evans rats (Charles River Breeding 
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Labs) weighing 200-450 gms. were group housed with food and 
water given ad libitum in a windowless room in which an 
artificial photoperiod was provided (light: 0800-1600 
E.S.T.). Animals were sacrificed by decapitation at approx-
imately the same time each day (11:00-12:00 noon) to elimi-
nate the possible source of error attributable to chronobio-
logical variations in the uptake of neurotransmitters as 
reported by Lew and Quay (1974). The latency from decapi-
tation to immersion of the dissected brain tissue into ice 
cold 0.32M sucrose never exceeded 1.0 minute and was usually 
accomplished within 45 seconds. 
Brains were dissected using a modification of the 
method developed by Glowinski and Iversen (1966). The 
brain was removed from the skull and placed with its ventral 
side upon a previously cooled glass plate positioned on ice 
(generally within 20 seconds from decapitation). An ice-
cold stainless steel spatula was used to make a medial-
saggi tal incision to the level of the corpus callosum. With 
the lateral ventricles as the starting point the cerebral 
cortex was rolled back laterally to expose the hemisphere 
of tissue containing the characteristic striae of the 
striatum. The medial aspect of the striatal tissue was 
teased free with the blade of the spatula. After removal of 
both striatal tissue masses the cortex was folded closed 
and placed on its dorsal surface. The end of a curved 
spatula was inserted at the posterior portion of the Circle 
of Willis and maneuvered in such a way as to emerge at its 
42 
anterior portion. The tissue was dissected free along the 
side edges of the spatula with a dissecting needle. Al-
though ref erred to here as hypothalamic this tissue mass is 
predominantly hypothalamic in origin with some mid-brain 
tissue as depicted in the diagram provided by Glowinski and 
Iversen (1966). The remaining tissue was placed on either 
lateral side and the hemisphere partially separated to 
observe the approximate location of the genu of the corpus 
callosum. The brain was then sliced in a coronal plane with 
the genu as its posterior boundary. This tissue mass was 
termed forebrain and contained cerebral cortex and some 
limbic structures. 
The dissected tissue was immediately placed into ice-
cold 0.32 sucrose (l()}b w/v) and allowed to sit on ice until 
all dissections were completed. The tissue was then homo-
genized in a TeflonR -glass tissue grinder with a clearance 
of 0.030 cm using 10 up and down strokes at about 1,000 
r.p.m. The supernatant fraction of a 1,000 x g x 10 minute 
centrifugation carried out at 4°c in a Sorvall RC-2B 
refrigerated centrifuge was used as the crude synaptosomal 
homogenate (CSR). 
The incubation medium (IM) originally used in prelimi-
nary experiments was Kreb's bicarbonate (Umbreit et al., 
1964), as modified by Snyder and Coyle (1969) and contained 
in millimoles (mM): NaCl (118.5), KCl (4.8) Cac12 (1.2) 
KH2Po4 (1.2) MgS047H20 (1.2), NaHC03 (24.8), d-glucose 
(11.1), ascorbic acid (1.1), disodium ethylenediamine tetra-
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acetic acid (EDTA) (0.13) and the monoamine oxidase inhib-
itor (MAOI), nialamide (0.01). The ascorbic acid and EDTA 
were added to increase the stability of the neurotrans-
mitters by preventing auto-oxidation shown to occur in 
oxygenated media (Iversen, 1972). 
One milliliter (ml.) of CSH was introduced into 6-8 ml. 
of incubation medium (IM) resulting in a concentration of 
0.4 to 0.9 mg. protein per ml. IM. Protein was determined 
by the method of Lowry et al. (1951). Usually, six aliquots 
were equally divided among o0 c and 37°C conditions. In 
some experiments the number of replicates per condition 
reached 8. 
The radio-labeled neurotransmitter (2uCi/ml) was added 
to the I M in a volume of 5 microliters (ul.) per ml. of I M 
resulting in an I M which was 0.1 uM with respect to neuro-
transmitter. One ml. aliquots (minimum of 3 and maximum 
of 8 determinations per condition) were incubated at 37°c 
in a Dubnoff metabolic shaker (with no agitation) and an 
equal number were kept on ice in glass test tubes (10 mm 
O.D. x 75 mm). After incubation for the specified time 
interval (norepinephrine and dopamine, 10 minutes; serotonin 
5 minutes) the tubes were placed into a Sorvall RC-2B ref-
rigerated centrifuge to spin at 13,000 x g x 60 minutes to 
form a pellet containing synaptosomes, mitochondria and 
microsomes or the P2 fraction described by Gray and 
Whittaker (1962). 
One-tenth ml. of the supernatant was placed into 
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scintillation vials containing 2 ml. of absolute ethanol 
prior to the addition of toluene phosphor scintillation 
fluid. Pellets were solubilized in 1.0 ml. of absolute 
etha.~ol with the aid of a bent dissecting needle used to 
break up the pellet and the solution was poured into a 
scintillation vial. The tubes were washed with 1.0 ml. 
of absolute ethanol and this wash was added to the scin-
tillation vial prior to the addition of scintillation fluid. 
Ten ml. of toluene phosphor containing 5.5 g/liter of 
2,5-diphenyloxazole (PPO) and 125 mg/liter of B-bis-(2-
phenyloxazole)-benzene (POPOP) in toluene. The radioactiv-
ity was counted in a Packard Tri-Carb Model 3335 for 10 
minutes. The efficiency for tritium was optimum (45%) at 
a gain setting of 57.5 with the window virtually wide open. 
Quenching between samples was not found to be significant 
and therefore no correction was made. Background counts 
was subtracted from all samples with counts less than ten 
times the value obtained for background. 
The data are expressed as either Tissue (or Particu-
late): Medium ratios or uptake in nanograms/mg. protein/10 
minutes (or 5 minutes where applicable). In preliminary 
experiments calculations were performed with the aid of a 
computer. Two programs were used the more complex of which 
is presented in the appendix, Figure A-1 is a flowchart and 
table A-1 is the program listing. The less complicated 
program was a modification of VIVO to allow for a single 
value of protein concentration per neurotransmitter (or 
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brain region) condition. 
Mean values obtained by incubating at 0-4°C were 
routinely subtracted from values obtained at 37°c as a 
control for non-specific adsorption of neurotransaitter to 
a variety of binding sites including plasma proteins and 
presumably the transport carrier itself. Uptake was not 
found to be saturable at 0-4°C over the concentration range 
0.04-2.0 uM. An untreated sample was used as a value 
representing maximal uptake with which drug treated samples 
were compared. Hypothalamic homogenate was used for nor-
epinephrine uptake studies striatal for dopamine and fore-
brain for serotonin. 
i) Determination of neurotransmitter integrity: 
The radioactive neurotransmitters used in this study 
were obtained from New England Nuclear Co. as H3-l-nor-
epinephrine (H3-l-NE: 5.85 Ci/mM), 5-hydroxytryptamine 
binoxalate (H3-5-HT: 2.2 Ci/mM), and dopamine ( DA: 1.0 Ci/ 
mM). The corresponding unlabeled compounds were obtained 
from Sigma Chemical Company as well as the 0-methylated and 
deaminated metabolites of the neurotransmitters. The 
unlabeled compounds were spotted on cellulose NM300 thin 
layer chromatographic plates in 10 ul. volumes containing 
1-5 ugms. of t he test substance as origi nally described by 
Giese et al. (1967). The plates were allowed to dry after 
spotting and were equilibrated i n a TLC t ank f or 30- 60 
minutes prior to i mmersion into t he solvent (butanol: 5N 
acetic acid=l00:35). The solvent travel was spotted after 
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approximately 15 cm. Clear separation of all the neuro-
transmitter was obtained and a test system for neurotrans-
mitter integrity was established by spotting the labeled 
neurotransmitter. After developing, the visualizable spot 
was scraped off and placed into a scintillation vial and 
counted. All adsorbent below the spot was placed into a 
scintillation vial as was all adsorbent after the spot. 
High counts found only directly on the visualized spot were 
interpreted to mean the neurotransmitter remained intact. 
Once radioactivity either before or after the visualized 
spot was apparent, the labeled neurotransmitter was no 
longer used. 
ii) Time course for incubation 
All samples incubated at 37°C were placed in the hot 
water bath and removed sequentially over the time intervals 
reported in the results. Another set of tubes identically 
prepared except that the labeled neurotransmitter was 
omitted, were placed in an ice-water bath. The labeled 
neurotransmitter was added at various times during the 
course of the total incubation time beginning with longest 
time interval sample (prepared just prior to introducing 
the 37°C samples into the heated water bath). All tubes 
were vortexed after addition of the labeled neurotrans-
mitter. Results are expressed as Tissue: Medium ratio 
calculated as ngms H3-l-NE gm-l brain:ngms. H3-l-NE ml.-l 
supernatant. This experiment was repeated 6 times with the 
brains of 2-6 animals pooled in different experiments. 
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iii) Synaptosomal concentration versus uutake 
The synaptosomal concentration was varied by delivering 
different amounts of the CSH to the IM and adjusting to an 
identical final sucrose concentration in each tube by the 
addition of an appropriate volume of 0.32M sucrose. The 
tubes were kept in an ice-water bath until the start of the 
experiment at which time half were transferred to the hot 
water bath for the previously specifie_d periods of time. 
The brains of two to six animals were pooled for each 
experiment and the experiment was repeated five times. The 
results are expressed as a Tissue (Particulate): Medium 
ratio calculated ngms. H3-l-NE/gm brain wet weight: ngms 
H3-l-NE/ml and supernatant in an attempt to demonstrate the 
concentrative property of the synaptosomal preparation. 
iv) Effect of calcium ions and ethylenediamine-tetra-
acetic acid 
An attempt to evaluate the contribution of facilitated 
exchange diffusion in the synaptosomal preparation was made 
by varying the calcium concentration in the media and 
employing ethylenediamine tetra-acetic acid (EDTA) to chel~ 
ate endogenous calcium. Six determinations were made at 
both 0 and 37°C. The mean of the six o0 c samples was sub-
tracted from each of the 37°c values followed by the trans-
formation to uptake expressed as ngms H3-l-NE/mg ptotein/ 
10 minutes. The media of Coyle and Snyder (1969) was used 
as a control to which greater or lesser concentrations of 
calcium were compared. 
The brains of six aminals were pooled and aliquots 
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were placed in media that was identical to the media of 
Snyder and Coyle (1969) except that calcium and EDTA were 
modified as follows. For the first condition, l.2mM cal-
cium was replaced with lOmM ca++ and EDTA was omitted. The 
calcium concentration was then lowered to 2.5mM in the 
second condition. The third condition employed was that of 
Snyder and Coyle (1969) as a control. In the fourth tube 
the medium was modified by deleting calcium and adding 0.1 
mM EDTA. The EDTA concentrations were increased logarith-
mically in subsequent tubes to 1.0 and lOmM. The pH was 
checked in each and found to require adjustment in the 10 
mM EDTA solution by the drop-wise addition of O.lN NaOH to 
bring the pH from 6.6 to 7.4. All other solutions were in 
the range 7.35-7.45. 
v) Kinetics 
Preliminary studies of the kinetics for the transport 
of biogenic amines into the CSH included all three neuro-
transmitters, 1-norepinephrine, serotonin and dopamine. 
Seven substrate concentrations used during preliminary 
investigations ranged from 2.0 to 0.01 uM (2-lOuCi/ml.). 
An aliquot of the supernatant was used as a measure of the 
total radioactivity in the media since the difference 
between I M and supernatant counts did not differ by more 
than 7% at any time. The brains of 2 animals were pooled 
and the media of Coyle and Snyder (1969) was used in the 
studies using serotonin and dopamine as substrate. 
1-Norepinephrine kinetics was performed with a calcium-
49 
free media supplemented with 0.1 uM EDTA. The substrate 
concentrations ranged from 2.0 to 0.01 uM (2-10 uCi/ml.). 
Three determinations were made for each condition and the 
data was transformed to uptake expressed in ngms H3-l-NE/ 
mg protein/10 minutes. The experiment was repeated three 
times. 
vi) Subcellular distribution of H3-l-norepinephrine 
Continuous sucrose gradients were prepared using a 
Beclanan Density Gradient former resulting in a linear 
gradient from 0.38 to l.4M sucrose in a 12 ml. volume. The 
gradients were prepared 3 hours prior to their use and 
stored in an ice-water bath until ready for use. The CSH 
was prepared as an outlined above and after incubation and 
subsequent centrifugation the pellet was resuspended in a 
1.0 ml. volume and layered onto the sucrose gradients. 
An identical aliquot of the CSR was prepared in media 
in which the monoamine oxidase inhibitor, nialamide, was 
omitted. Unlabeled 1-NE was added to a final concentration 
of 0.1 uM and processed in an identical manner as the radio-
active sample. 
The gradients were centrifuged for 90 minutes at 
130,000 x g in an International ultracentrifuge using a 
swinging bucket rotor. Fractions were obtained by piercing 
the bottom of polyallomar centrifuge tubes and collecting 
·0.4 ml. fractions. 
The samples containing radioactive neurotransmitter 
was assayed for tritium by placing 0.1 ml. samples into 
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scintillation vials containing 2 ml. of absolute ethanol to 
which 10 ml. of toluene phosphor was subsequently added. 
Unlabeled neurotransmitter samples were assayed for 
monoamine oxidase activity by a modification of the method 
of Wurtman and Axelrod (1963). A 0.1 ml. aliquot of the 
sample was added to 0.25 ml. of phosphate buffer (pH 7.4) 
in a test tube. c14-tryptamine was added and the tubes 
were incubated at 37°c for twenty minutes. The reaction 
was stopped by the addition of 0.2 ml of 2N HCI and the 
indole acetic acid formed was extracted into 6 ml. of 
toluene by shaking. Four ml. aliquots of the toluene were 
placed into scintillation vials and 10 ml. of toluene 
phosphor added prior to counting. The results obtained are 
expressed as percent of radioactivity in each fraction com-
pared with the sum of all fractions. 
vii) Regional distribution of neurotransmitter uptake 
The uptake of each neurotra~smitter into each brain 
region employed in this study was investigated. The method 
employed was similar to that outlined above in methods 
except that all these brain regions were studied for each 
neurotransmitter. The media used was that described by 
Snyder and Coyle (1969). 
The results are expressed as Particulate: Medium ratio 
calculated as CPM/mg protein/Incubation time: CPM/ml. super-
natant. 
viii) Effect of calcium in 1-norepinephrine release 
induced by hi-potassium depolarization 
The role of calcium in the release of norepinephrin'e 
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and its consequent effect on uptake was studied. The 
hypothalami of ten animals were pooled and divided into 
equal aliquots. Preincubation media used were as follows: 
(1-2) hi- K+ (45mI~ ) plus ca++ (2.5 mM), (3) normal Kreb's 
(2.5 mM Ca++) and (4) hi-K+ less Ca++. The hi- K+ media 
was prepared by equimolar replacement of Na+ by K+ . The 
CSR aliquots were incubated in twice the normal incubation 
medium volume resulting in a protein concentration of 0 .24 
mg/ml. Incubation was carried out at 37°c for 15 minutes 
with continuous oxygenation of the media with o2 :co2 (95:5). 
The tubes were then centrifuged at 15,000 x g for 15 minutes 
and the resultant pellets reconstituted with modified Kreb's 
(i.e. no ca++ + 0.1 mM EDTA) in half the volume used for 
the preincubation. To tube #1 was added the diluent for 
the neurotransmitter. To the second tube was added a cal-
culated amount of unlabeled neurotransmitter required to 
completely refill the synaptosomes (to 1 ugm/g tissue wet 
weight). Tube 3 received neurotransmitter diluent as did 
#4 and all tubes were incubated for 30 minutes at 37°c. 
Following centrifugation at 15,000 x g for 15 minutes the 
pellets were resuspended in modified Kreb's media to which 
H3-l-NE was added to achieve a resultant concentration of 
0.1 uM and four one ml. aliquots of each tube were incubated 
at o0 and eight one ml . aliquots were incubated at 37°c for 
10 minutes . All tubes were then centrifuged at 13,000 x g 
for 60 minutes in a Sorvall RC-2B centrifuge. The pellets 
were solubilized in the usual manner described in the gen-
52 
eral methods. The data was calculated as ngm H3-l-NE/mg 
protein/10 minutes and expressed as percent of control. 
ix) IC~0 for some representative tricyclic anti-depressants 
The ability of tricyclic antidepressants to block the 
uptake of labeled neurotransmitter by 50 percent (i.e. Ic 50 ) 
was studied by varying the concentration of antidepressant 
using 4 concentrations increasing progressively by one 
order of magnitude. The uptake of neurotransmitter calcu-
lated as ngms H3-l-NE/mg protein in the drug treated 
samples were then compared with an untreated control and 
expressed as a percent of control. The concentration of 
drug resulting in uptake representing 50'/o of control was 
determined graphically and described in the results. 
x-xi) Protriptyline - acute and subacute time course 
Protriptyline was administered intraperitoneally 
either acutely (20 mg/kg) or subacutely (lOmg/kg ) at varying 
times prior to sacrifice as stated in the results. Acute 
refers to a single injection prior to sacrifice, whereas, 
subacute refers to 6 consecutive days of injections. On 
any given day two animals from each treatment condition was 
represented to randomize day to day experimental variations. 
The animals were sacrificed at approximately the same time 
each day necessitatingaschedule of injection running through-
out the day (i.e. 5:00, 9:00, 11:00 A. M. and 11:00 P. M.). 
Three determinations were made for each condition (i.e. 
o0 c and 37°c). Incubations were performed in modified Kreb's 
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media (no Ca++ + O.lmM ED'rA). 
xii) Protriptyline - chronic time course 
One hundred animals were randomly assigned into five 
groups of twenty animals each. These five groups were ad-
ministered either saline or drug beginning on five consecu-
tive days. Within each group of twenty, four groups of 
five animals each represented either saline injected con-
trols or 2, 6 and 24 hour post-protriptyline (10 mg/kg i.p.) 
injected treatments. The brains of 5 animals in each group 
were pooled prior to homogenization and the uptake study 
was carried out over the course of 5 days after 18 consecu-
tive days of injections for each group of twenty animals. 
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c. Results and discussion: 
Included in the results sections are discussions per-
taining to the individual experiment which serve to develop 
a sense of continuity and an appreciation for the course of 
investigation taken in this thesis. The general discus-
sion to follow considers the results of the research pre-
sented here as it relates to more general considerations of 
the possible mechanism(s) of action of tricyclic anti-
depressants. 
The terminology used in the literature with respect to 
neurotransmitter transport studies is governed largely by 
the methodology employed (Graefe, 1976). Although the 
definitions reviewed here are not strictly adhered to in 
the literature, it is useful to describe the differences 
and establish the terminology used in thi:s report. "Uptake" 
of amines can be defined as transmembranous flux into the 
cell regardless of whether or not intracellular accumula-
tion of the substrate occurs. Many studies attempt to 
measure "net uptake" which takes into account the accumula-
tion of unchanged amine by the tissue preparation. The 
tissue preparation can lose accumulated amines by MAO met-
abolism and a common approach is to inhibit MAO in an at-
tempt to obtain an estimate of net uptake. The use of 
amines which do not undergo metabolism by M.AO (e.g. metar-
aminol) is an alternate approach to obtain a measure of net 
uptake. In either case the measurement only approaches the 
tm.e value of net uptake because exchange processes are 
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usually not considered by investigators. There is suffi-
cient evidence to suggest that both hetero-exchange as well 
as homo-exchange processes do occur (Cohen & Lajtha, 1972; 
Levi et al., 1976). Many studies use short incubation times 
to maximize the magnitude of unidirectional flow of sub-
strate and prolo:1ged incubation usually results in a devia-
tion from linearity. "Re-uptake" refers more to the process 
in-situ and i :s inappropriately used as a synonym for uptake. 
This thesis utilized the term uptake to represent an appar-
ent accumulation of amines and assumes that exchange pro-
cesses are not significant over the short incubation times 
used. 
General: 
The reproducibility of the brain dissection procedure 
is reported in table 1 and compares favorably with the values 
reported by Glowinsky and Iversen (1966). Since the bound-
aries differ some, the difference in values between those 
published and reported here appear to be reasonable. The 
weighed brain regions were carried through the homogeniza-
tion procedure and the functional relationship between the 
wet weight of brain tissue for a given brain region and the 
resultant concentration of protein in the I M was determined 
as shown in figure 1 for the hypothalamus. From the inter-
section of two regression lines (i.e. y on x and x on y) the 
mean values of both variables are obtained. From these 
values corrections for dilution can be made and the appro-
priate relationships between mg protein (as a crude measure 
of synaptosomal concentration) and a gram oi' tissue wet weight 
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Table 1. Reproducibility of the brain dissection procedure 
Brain region 
Hypothalamus 
Fore brain 
Striatum 
Tissue wet weight (X ± s.e.m.) 
133 ± 8 
199 + 8 
85 + 4 
Mean weights for various brain regions dissected from 24 
animals. 
Figure 1. 
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Functional relationship between brain tissue wet 
weight and resultant protein concentration in the 
incubation medium. 
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can be formulated. One gram of forebrain, hypothalamus and 
striatum are equivalent to 460, 300 and 285 mg protein 
respectively. Conversions from mg protein to grams wet 
tissue weight were made using these relationships. 
i) Neurotransmitter integrity 
The functional integrity of the substrates used in bio-
chemical systems of the type reported here is an important 
consideration with respect to interpreting the results. 
Structual changes of the substrate molecule can result in 
drastically altering the observed kinetic constants as well 
as possess inhibitory properties themselves as outlined inthe 
literature review. Monitoring the integrity of the neuro-
transmitters is important and' can be accomplished in at 
least two ways. A simple method is to use chromatography 
to identify the substance by separating it from closely 
related molecular species. The procedure outlined by Giese 
et al. (1967) and reported here clearly resolved all three 
neurotransmitters with virtually no overlap in the resul-
tant radio-chromatogram shown in figure 2. De-aminated and 
0-methylated metabolites were shown to possess clearly dis-
tinguishable spots on the developed chromatogram. The thin 
layer chromatographic (TLC) procedure was performed between 
series of experiments on both the unlabeled stock solution 
as well as the radioactive neurotransmitter. 
A method for the detection of specifically inhibitory 
contaminants in radioactive substrates is described by 
Timpton et al. (1977). The advantage of this procedure is 
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Figure 2. Integrity of radioactive neurotransmitter sub-
strates determined by thin layer chromatography. 
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Figure 3. Effect of incubation time upon the uptake of 
H3-l-NE into hypothalamic crude synaptosomal 
homogenate. 
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minutes). Similar results were obtained for DA uptake into 
striatal CSR. These results agree with those published 
(Coyle and Snyder, 1969; Snyder and Coyle, 1969). Serotonin 
uptake was linear for six minutes and this value agrees 
exactly with that reported by Shaskan and Snyder (1970). 
Wong et al. (1973) demonstrated linearity for 5HT uptake for 
at least 3 minutes and the difference may be accounted for 
by the use of a 5 minute pre-incubation or equilibration of 
the IM prior to introducing the radioactive neurotransmitter 
and as well as a lower incubation temperature (30°c). One 
more complicating factor includes the use of a velocity 
term as the ordinate of the time course curve presented by 
these investigators. The velocity term (nM/mg protein/3 
min) requires each value for uptake at each time point to 
be corrected for uptake over 3 minutes. Making the appro-
priate correction from the velocity term to a concentration 
term (nM/mg protein) results in a linear function for at 
least 5 minutes . As a result of these experiments, incu-
bation times for the uptake of NE and DA of 10 minutes were 
established and 5 minutes for 5-HT. The Tissue: Medium 
ratio shown in figure 3 demonstrates that the process at 
o0 c seems to be one of adsorption or diffusion whereas at 
37°c a concentrative phenomenon appears operative with 
ratios as high as 4. Dopamine uptake gave ratios one order 
of magnitude higher than those of 5-HT or NE. The tremendous 
concentrative power of dopaminergic nerve endings in the 
striatum may be as a result of finer nerve terminals 
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resulting in increased surface area for uptake as suggested 
by Glowinski and Iversen (1966). 
iii) Synaptosomal concentration versus uptake 
The concentration of tissue in the incubation medium 
was shown to vary considerably as a result of the variation 
in the dissection procedure. Another source of this type of 
variation is the physical size of the brain which varies 
with the age or weight of the animal. Differences in pro-
tein concentration (assumed to be a measure of synaptosomal 
concentration) was studied in order to understand the nature 
of this variable and apply whatever corrections seemed nec-
essary. The results shown in figure 4 for H3-l-NE are 
representative of the results found for the uptake of 
labeled 5-HT and DA. The points represent the mean of 3 
determinations with the coefficient of variation less than 
10% for values above 0.5 mg protein per ml. of I M. Values 
below 0.5 mg had a much larger degree of variability assoc-
iated with their means. The resultant curves were calculated 
using the original data points by polynomial regression. 
The data was shown to be satisfied best by the second degree 
polynomial equations shown in the figures with their atten-
dent levels of probability. 
Two interesting points can be made by observation of 
figure 4. First, the ordinate is expressed as uptake in 
ngms H3-l-NE corrected for mg protein. Theoretically, if 
increasing synaptosomal concentrations results in an increase 
in uptake described by a linear function, one might expect 
Figure 4. 
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Effect of synaptosomal concentration in the 
incubation medium upon the uptake of H3-l-NE 
into hypothalamic crude synaptosomal homogen-
ate. 
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that uptake corrected for mg protein would be a straight 
line with a slope close to zero. At concentrations of pro-
tein greater than 0.5 mg/ml. this theoretical curve appears 
to be approximated fairly well. 
The tremendous increase in uptake demonstrated at low 
synaptosomal concentrations may be explained by an increase 
in membranous surface area. Since the uptake is increased 
for both O and 37°c one might conclude that the increase is 
due to adsorption to the membranous particles whose surface 
area increases tremendously as a result of dilution. Concen-
trations above 0.5 mg/ml. may reflect a state where by a 
certain degree of clumping occurs resulting in minimizing 
the surface area exposed to media substrate. This clumping 
effect appears not to increase tremendously over the range 
0.5 - 1.1 mg protein/ml. I M although a slight decline in 
uptake may be detected with increasing concentrations of 
protein. 
Secondly, it may be noted that the difference between 
uptake at 37°C and o0 c is constant for any synaptosomal con-
centration. This finding is important for it implies there 
is no effect of packing upon the measure of protein. Inter-
estingly, the relationship holds for low synaptosomal con-
centrations where, admittedly, the variability is high. An 
attempt was made to stay within the specified range where 
variability was lowest. Similar relationships for striatal 
and forebrain tissue were found and the critical values 
obtained were 0.16 and 0.25 mg protein per ml. I M respectively . 
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iv) The effect of calcium and ethylenediamine-tetra 
acetic acid 
The results of manipulating the calcium concentration 
in the media are presented in figure 5. A one-way analysis 
of variance of this data resulted in rejection of the hypo-
thesis that the means were equal at P<.005 (Fobs=33.9 compare 
with F(5, 26;0<=.005)=4.38). An F test for homogenity of max 
variance demonstrated no violation of the assumption. A 
Student-Neumen-Keuls test for differences between treatment 
means indicated that the Snyder and Coyle (1969) medium 
resulted in uptake significantly different from that 
obtained with normal Kreb's medium(Snedecor and Cochran, 
1967). When calcium was removed from the medi-u:r: and 0.1 :mM 
EDTA added, the uptake into hypothalamic synaptosomes was 
shown to be significantly greater than the value obtained 
using the mediUJ:Jof Snyder and Coyle (1969). Higher concen-
tration of EDTA resulted in attenuation of the response. 
Much mystery still surrounds the role of calcium in 
stimulus-secretion coupling mechanisms of neurotransmitter 
release (Rubin, 1970; Phillis, 1974; Baldessarini, 1975). 
As has been pointed out earlier in this report, preliminary 
experiments were performed using the mediumdescribed by 
Snyder and Coyle (1969). The rationale for its use was 
never made clear in the literature. In 1968, Snyder et al. 
reported the results of kinetic experiments of racemic H3-
NE in brain slices. The medi~mdescribed was both normal 
Kreb's and an ascorbate, EDTA and pargyline supplemented 
Figure 5. 
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Effect of altering calcium concentrations in the 
incubation media upon H)-1-NE uptake into hypo-
thalamic crude synaptosomal homogenate. 
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Kreb's. The authors suggested that EDTA and ascorbate 
reduced auto-oxidation and pargyline prevented the formation 
of deaminated metabolic products of NE, but calcium levels 
were not reduced. Subsequently, Snyder and Coyle (1969) 
published the use of their calcium reduced mediu~and it has 
been used in subsequent studies with no attendant discussion. 
EDTA is a chelator of divalent cations. The molar 
ratio of divalent cation to chelate molecule is, at the 
theoretical limit, equal to two. Since EDTA possesses four 
carboxylic acid groups it is theoretically possible for two 
calcium ions to electrically neutralize one EDTA molecule . 
EDTA , however, is not specific for chelating calcium, ~artell 
and Sillen (1964, 1971) report the metal chelate stabilities 
of EDTA to be greater for Cu (11), Zn (11) and Fe (11) by 70, 
49 and 30 % than for calcium. Magnesium has a stability 
constant 23% lower than calcium. 
Complex ion-chelator formations may also occur in acidic 
media by protonation of the amine groups. Therefore , it is 
with considerable conserative bias that the theoretical 
stoichiometric limit of 2 moles of ca++ required to form a 
complex with one mole of EDTA is used to calculate divalent 
ion equivalency in the various media employed. Theoretically 
then, 0.13 mM EDTA would complex 0.26 mM ca++ rendering the 
media of Snyder and Coyle equivalent to 0.99 mM ca++Kreb's . 
In consideration of the conservativeness eluded to above, a 
ca++ concentration slightly higher than this might be more 
equivalent to the Snyder and Coyle medium . 
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In a separate experiment the uptake of 1-NE into hypo-
thalamic CSH was measured using the Snyder and Coyle medium 
compared with 1.25 mM ca++ Kreb's. The results, analyzed 
using a two-tailed t-test did not show the means to be 
significant at P(.05 although the 1.25 mM ca++ mean value 
obtained was approximately 99~ below the value obtained 
using the Snyder and Coyle medium. Acceptance of the null. 
hypothesis suggests that the two media may be equivalent 
with respect to the availability of ca++ ions. 
The media of Snyder and Coyle was chosen in an attempt 
to duplicate the experimental protocol and compare the 
results as an aid to characterization of the system. Sub-
sequent to these preliminary studies use of the med:i.u;-r.was 
questioned and prompted this experiment. The choice of 
deleting calcium and adding EDTA was made using purely 
theoretical considerations. Since uptake studies attempted 
measuring unidirectional flux it was reasoned that efflux 
of endogenous amines in calcium enriched media might con-
found the results. Indeed both homo-and hetero-exchange 
processes are known to occur in transport systems of neuro-
transmitter amino acids (Cohen and Lajtha, 1972). ,1 Pre-
venting the calcium dep·endent process would serve to reduce 
the accumulation of label by reducing its specific activity 
in the IM. Controlling dilution by calcium-independent or 
spontaneous release of endogenous neurotransmitter is not 
possible and should be considered as a source of error in 
any estimate of unidirectional transmembranous flux of 
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neurotransmitter molecules. 
The results indicate that removal of calcium, up to a 
point, does result in an increase in the value of uptake. 
Increasing the EDTA concentration beyond 0.1 mM results in 
a dose dependent decline in uptake. Interestingly, Rajan 
et al. (1977) reported a dose dependent inhibition of H3-NE 
binding by metal chelators in mouse cerebral vesicles in 
vitro. It is possible then that high concentrations of 
chelating agent interfere with metal coordination complex 
formation within vesicles. It is also possible that since 
the chelating agents bind to copper and iron, high concen-
trations of chelators may interfere with cell respiratory 
l . . th t 1 . processes requiring ese me a ions. Either mechanism may 
result in the attenuation of uptake demonstrated at high 
EDTA concentrations. 
Blaustein et al. (1972) demonstrated a 37% decrease in 
synaptosomal norepinephrine release from a calcium-free 
normal Kreb 's medium compared with 2.5 mM ca++ normal Kreb's. 
The magnitude of this release, calculated from the data 
provided in the paper and making the assumption that one 
rat brain weighs approximately 2 grams, results in a value 
of 2.2 ng NE/g wet weight/min released into the normal 
Kreb's medium and 1.45 ng NE/g wet weight/min in ca++_free 
Kreb's. The data presented in figure 5 demonstrates a 54% 
increase in uptake using a ca++_free EDTA-enriched medium 
when compared with normal Kreb's. The value of uptake 
obtained in the experiments described in this thesis are 
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5.5 and 8.5 ng/NE/g/min in normal Kreb's and calcium free 
EDTA enriched Kreb's respectively. These figures indicate 
that ca++ independent or spontaneous neurotransmitter 
release may contribute significantly to homoexchange pro-
cesses confounding a measurement of unidirectional flux into 
synaptosomes. 
Kant and Meyerhoff (1977) studied the effect of calcium 
on norepinephrine release from hypothalamic tissue minces. 
These authors compared the release of NE in a normal Kreb's 
versus a calcium free Kreb's media at o0 c and reported a 
seemingly insignificant increase (5%) of release in normal 
Kreb's. Lane and Aprison (1977) reported all three neuro-
transmitters (i.e. NE, DA & 5-HT) to behave similarly. Since 
the release of endogenous neurotransmitter can be minimized 
by modifying the media all subsequent experiments reported 
here have been performed with calcium-free EDTA enriched 
(O.l mM) Kreb's media referred to herein as "modified Kreb's". 
v) Kinetics 
Characteristics of transport systems of t he type used 
in this study have been determined using relationships des-
cribed by enzyme kinetics. Linear transformations of the 
rriichaelis-Menten equation leads to graphical techniques for 
the determination of kinetics constants (i.e. Km and V ). 
max 
A number of linear transformations are possible and most are 
reviewed in standard texts on enzyme kinetics (Roberts, 1977). 
In recent years a growing number of investigators have be~ 
come concerned with the validity of the methods employed. 
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The most popular method by far is that of Lineweaver -Burk 
(1934), although Dowd and Riggs (196~) demonstrated that 
this method led to least accurate determinations of kinetic 
constants whether the curve was plotted by eye or using the 
r 
method of least squares. The Hofstee plot (S/v vs. S) was 
considered the most favorable since it was viewed that of 
the two variables Shad less error associated with it than 
v. Estimates of kinetics constants can be obtained using 
non-linear statistical techniques (Cleland, 1967; Wentworth , 
1965a, b) but these methods require iterative procedures and 
have not demonstrated popularity among biochemists. Elmore 
et al. (1963) applied a linear regression technique to the 
Lineweaver-Burk transformation which accounted for the 
variability associated with each data point. Wilkinson 
(1961) applied a similar technique except that a weighting 
factor was used with the assumption that the distribution 
of the observations of the velocity about a given substrate 
concentration was directly proportional to the magnitude of 
the velocity. This assumption can be shown to be true in 
many biological systems where analysis using Michaelis-
Menten kinetics apply. Probably the best method from the 
standpoint of a mathematical approach to the determination 
of kinetic constants is that of Wilkinson (1961) although 
it requires the assumption of normally distributed data as 
any parametric method does. 
Recently, a graphical method for the ·analysis of kin-
etic data called the direct linear plot (DLP) has been 
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re·ported by ~isenthal and Cornish- 3 owden (1974). _Ton-para 
metric statistical considerations supporting the use of t his 
method have been describ ed (Cornish- Bowden and Eisenthal, 
1974; Trager and Porter , 1977). The advantage to the direct 
linear plot , over the other methods as pointed out by the 
authors is that it is simple to construct with kinetic con-
stants read directly off the graph without calculations as 
is done with reciprocal plots. It is extremely sensitive 
to outliers or abberant observations and provides accurate 
determinations of kinetics constants. 
The kinetics data for 1-NE uptake into hypothalamic 
CSE was analyzed using a number of different methods , some 
graphical and some statistical. The results obtained by 
various methods are shown in table 2. Th e easiest to pre-
pare. The kinetics constants obtained were compared and the 
results obtained indicate the ·direct linear plot to be as 
good an estimator of the kinetics constants obtained by 
either Wilkinson (1961) regression or the standard para-
metri c linear regression model described by Elmore et al . 
(1963). 
The DLP was used in the calculation of all kinetics 
data reported here and is described briefly to acquaint the 
reader with the technique. The interester reader is refered 
to the original references of Cornish- Bowden and Eisenthal for 
the theory and a more thorough discussion of techniques and 
applications. The DLP is so named " ••• because it represents 
each observation by a straight line, ••• "and utilizes the 
concept of plotting data in parameter space rather than 
Table 2. Comparis·on of methods used to determine kinetics constants for H3-l-NE uptake 
into rat hypothalamic CSH 
Km {uM) 
0.308 
0.239 
0.236 
0.262 
+ 
-.018 
0.276 
0.235 
Ymax (ng/mg prot/lOmin) 
2.85 
2.434 
2.40 
2.539 
±.098 
2.628 
2.340 
Method 
l/v vs. l/S 
S/v vs. S 
v/S vs. v 
reduced weighted 
regression 
assuming constant 
coefficient of 
variation 
weighted linear 
regression 
Direct Linear 
Plot 
Reference 
Lineweaver-Burk, 1934 
Woolf plot 
(Haldane & Stern, 1932) 
Augustinson (Hofstee ) 
Johansen & Lumry, 1961; 
Wilkinson, 1961 
Steel and Torrie, 1960; 
Elmore, Kingston & 
Shields, 1963 
Eisenthal & Cornish-
B ow den, 1974 
-J 
-i::.. 
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observation space. The ordinate is labeled Vmax and the 
abscissa Km and the corresponding set of observations, i.e. 
v and S, are represented as points on the abscissa and 
ordinate, respectively. A line is drawn through each set 
of data points and is continued as far as possible into the 
first quandrant. The data for 1-NE kinetics is shown in 
figure 6 using the DLP. It can be demonstrated that for n 
pairs of observations there exists 1/2 n(n-1) intersections 
of the lines extended into the first quandrant. The non-
parametric theory specified the most likely unbiased 
estimator of the parameters to be determined is given by the 
point associated with the median of all interecting lines. 
That point can be taken from the associated values of the 
axes labeled Km and Vmax· For 6 data points there are 6/2 
(6- 1)= 15 intersections with the median being the point 
described between the points designating the seventh and 
eighth intersecting lines. Two intersecting lines yields 
one point whereas three intersecting lines corning close to 
the same place can be shown to be represented by three 
points. Counting may begin from the low left corner of 
quadrant 1 and proceed to the upper right. The first circle 
represents 4 intersecting lines or 5 intersections. Since 
we are interested in that intersection which falls between 
7 and 8, that intersection must be in the second circle (i. 
e. between intersections 4 and 9). 
Comparisons of the kinetic data obtained using the DLP 
with reported values are presented in tables 3, 4 and 5 for 
Figure 6. 
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'Direct Linear Plot' of H3-l-NE uptake into 
hypothalamic crude synaptosomal homogenate. 
Vmax :i:: 2.50 
Vmax 
(ngm H!·l-NE/mg PROTEIN(IO min) 
-o.4o -o.32 -0.24 -0.16 -o.oe 0 o.oe 0.16 0.2~ o.32 o.~o 
Km (uM) 
Table 3. Kineti c constants obtained for norepinephrine uptake using substrate 
concentrations in the high affinity range. 
Km v 
(uM) (nM/gm¥min) 
-
. 0.4 0.11 
, 0.48 0.71 
0.4 1.66 
0.2 N/A 
0.5 N/A 
0.2 - 0.4 0.33 - 0.40 
0.227 0.413 
Reference 
Ross and Renyi, 1964 
Salama et al., 1971 
Snyder et al. , 1968 
Ross and Renyi, 1975 
Ross and Renyi, 1975 
Shaskan and Snyder, 1970 
This study 
Remarks 
d, 1-NE mouse 
cortex slices 
d, 1-NE rat 
brain slices 
d,1-NE rat 
brain slices 
1-NE rat brain 
synaptosomes 
1-NE rat brain 
slices 
d, 1-NE 
synaptosomes 
hypothalamus 
calcium-free plus 
EDTA enriched 
medium 
-1" 
-..J 
-..J 
Table 4. Kinetic contants obtained for serotonin uptake using substrate concentrations 
in the high affinity range. 
Km 
(uM) 
0.7 
0.1 
0.14-0.31 
0.08 
o.6 
0.15 
v 
(nM/g ~atnin) 
0.23 
1.13 
o. 66-0.82 
N/A 
N/A 
0.84 
Reference 
Ross and Renyi, 1969 
Wong et al., 1973 
Shaskan and Snyder, 1970 
Ross and Renyi, 1975 
Ross and Renyi, 1975 
This study 
Remarks 
mid-brain 
mouse slices 
rat brain 
synaptosomes 
rat brain 
synaptosomes 
rat brain 
synaptosomes 
rat brain 
slices 
Medium of 
Snyder and 
Coyle ( 1969) 
N/A The information was not available in the cited paper. 
-....] 
m 
: 
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Table 5. Kinetic constants obtained for dopamine uptake 
using substrate concentrations in the high 
affinity range. 
Km 
(uM) 
0.31-0.4 
0.13 
v 
(nM/g ~atnin) 
4.08-5.0 
5.08 
Reference 
Shaskan and Snyder, 1970 
This study 
8 0 
NE, 5-HT and DA respectively. The data appears in good 
agreement with the values reported by other investigators. 
Small differences may be due to the tissue preparation used 
(slices vs. synaptosomes) as well as the duration of incu-
bation which can result ·in larger differences in the V max 
values. These results suggest that the experimental proto-
col as used here yields results that are similar to those 
obtained in other laboratories. Further support for this 
conclusion is offered in a review of the in-vitro data of 
section ix. 
vi) Subcellular distribution of H3-norepinephrine 
uptake 
An attempt to characterize t he functional integrity of 
the synaptosomal transport system was made by separating 
some of the constituents of the CSH. The synaptosomes are 
known to be confined to a region on the sucrose gradient 
corresponding to 1.1 molar (Gray and Whittaker, 1962). 
Mitochondria are known to sediment below 1.2 M sucrose and 
monoamine oxidase activity is taken to be a marker for 
mitochondria (Laduron, 1977). In figure 7 it can be ob-
served that the radioactive neurotransmitter concentration 
is highest at the synaptosomal fraction and some label can 
be seen associated with myelin and microsomes as might be 
expected due to adsorption. The supernatant possesses a 
large degree of label but little or no ri!.A O activity. This 
evidence suggests that t he CSH is selectively incorporating 
radioactive n eurotransmitter within the synaptosomal fraction 
and there is little contamination of uptake into either 
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Figure 7. Subcellular distribution of nreviously accumu-
lated H3-l-NE into hypothalainic crude synapto-
somal homogenate. 
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mitochondrial or microsomal components. 
vii) Regional distribution of neurotransmitter uptake 
The selection of brain regions for studying the uptake 
of different neurotransmitters was based on the rationale 
that selection of brain regions with a high concentration 
of nerve terminals would result in a greater degree of 
uptake compared with non-specific binding. Snyder and Coyle 
(1969) used hypothalamus for norpeinephrine and striatum for 
dopamine uptake studies. Kuhar et al. (1972) used forebrain 
for serotonin uptake studied. Confirmation of this selection 
of brain regions was attempted by studying the uptake of each 
neurotransmitter in each brain region. Figure 8 depicts the 
results. Each value and its associated variation represents 
the results obtained from 3 animals. Dopamine uptake is 
unquestionably greatest into the striatal tissue although a 
fair amount of dopamine can be taken up into hypothalamic 
tissue presumably into noradrenergic as well as dopaminergic 
neurons to some degree (Coyle & Snyder, 1969). N orepin- , 
phrine uptake, although large in the striatum, may represent 
uptake into dopaminergic and other nerve terminals. 
Hokefelt (1970) estimated the noradrenergic contribution 
towards total catecholamines in the striatum to be 5% based 
on histochemical observations. The selection of tissue for 
uptake is similarly clear with greatest values obtained for 
serotonin uptake into forebraintissue. 
The choice of NE into hypothalamus appears to be 
governed more by tradition and concentrations of all three 
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Figure 8. Regional distribution of high affinity neuro-
transmitter uptake. 
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neurotransmitters are shown to be equivalent in the hypo-
thalamus (Anden et al., 1966). 
viii) Effect of calcium in 1-norepinephrine induced 
release by hi-potassium depolarization 
This study was prompted by the observation that a 
tremendous degree of variability occured in the in-vitro 
measurement of uptake after intraperitoneal administration 
of protriptyline. In an attempt to uncover the source of 
this variability it was reasoned that endogenous neurotrans-
mitter may influence uptake. The results of this experiment 
are presented in table 6. Although the data presented here 
could not be shown to differ using an analysis of variance, 
the data can be taken to . suggesta trend. Stimulation of 
release of endogenous neurotransmitter by hi-K+ depolar-
ization resulted in greater uptake when compared with tissue 
identically processed in normal Kreb's. Depleting the 
synaptosomes by hi-K+ in the absence of ca++ results in a 
value of uptake intermediate between what can be considered 
a greater and lesser degree of emptying. Refilling the 
synaptosomes with unlabeled NE and subsequently incubating 
with labeled neurotransmitter results in a value higher 
than that obtained for the same treatment except for refill-
ing. 
The results appear predictable. Removing neurotrans-
mitter from the synaptosomes may reasonably result in 
greater uptake by increasing the physical capacity to 
accumulate neurotransmitter taken up. Kant and Meyerhoff 
(1977) demonstrated at 17.5% increase in NE released by 
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Table 6. Effects of Hi-K+ depola,ization pretreatment upon 
subsequently measured H -1-NS uptake 
Tissue: Medium ratio. (CPM/gm. brain:CPM/ml. supernatant) 
Percent of Control (r-foans ± s. e. m.) 
Normal Kreb's 
100 ± 27 160 + 43 
-- · rr+ h l.- n.. 
without ca++ 
139 + 18 
NE prefilling 
Hi-K+ 
with ca++ 
177 + 49 
8 6 
Hi-K+ in the absence of ca++ which can be used to explain 
the reason for an increase in uptake over normal Kreb's. 
The fact that uptake is increased in normal ca++ Hi-K+ as 
opposed to ca++ free Hi-K+ media suggests that exogenously 
administered NE may equilibrate with both neurotransmitter 
compartments (i.e. vesicular and cytoplasmic). 
The increase in uptake measured in the refilling con-
dition appear inconsistent with notions regarding the dis-
tribution of neurotransmitter within the synaptosome. 
Classical theory considers norepinephrine to be bound with 
a protein, chromagranin A, ATP and Mg++ (Cooper, Bloom & 
Roth, 197~). It is also postulated that a mobile pool 
exists within the vesicle (Kirshner, 1962). The exact 
relationship between the uptake of exogenously administered 
norepinephrine and subsequent compartmentalization between 
vesicles and cytoplasm is not lmown. Release studies using 
preloading techniques make the assumption of equal distri-
bution inherently. It might appear then that previously 
accumulated norepinephrine distributes itself to some 
extent in both compartments and in doing so may result in 
inhibiting any further uptake of exogenously applied neuro-
transmitter by mass action. The results indicate quite the 
contrary and may be interpreted to reflect an uneven dis-
tribution within compartments. Although admittedly specu-
lative, one explanation may be that recently accumulated 
neurotransmitter is inactivated or bound by vesicular com-
plexing components. This binding would reduce the outward 
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flow of previously accumulated neurotransmitter and may 
result in a priming effect on intra-vesicular Mg-ATP-protein 
complex. Alternatively, high cytoplasmic concentrations of 
accumulated NE may result in a greater rate of exchange so 
that uptake may appear to increase overall but net uptake 
does not change. Answers to these questions are experiment-
ally approachable and in view of the fact that Grahame-Smith 
and Parfitt (1970) report similar results with 1-tryptophan, 
a study of this type may help to elucidate the compartment-
alization of exogenously administered neurotransmitter. 
ix) ICso for some representative tricyclic anti-
depressants 
There are, as in obtaining kinetics constants, differ-
ent methods used to calculate the rc50 for a compound with 
respect to particular response. Ross and Renyi (1967) 
introduced the concept of an uptake blocker standard (l.O x 
l0-4M cocaine) by which other compounds of varying doses 
could be compared. The data is reported as percent of total 
inhibition and the rc50 calculated by graphic observation of 
the resultant log dose-response curve. Another alternative 
is to use a vehicle-treated (or untreated) control and com-
pare the value obtained for drug treated samples with those 
obtained for controls and represent the data graphically as 
in the log dose-response curve of figure 9. The results in 
this figure are the means obtained in four separate experi-
ments when drug treated samples wher·ecompared with an un-
treated control. The resultant points were connected by a 
straight line using visual methods and the point at which 
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Figure 9. Graphical determination o! IC5o's. 
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uptake is equivalent to 5<Y/o of control was taken directly 
by dropping a perpendicular line to the log dose axis. 
Use of the logarithmic transformation for biological 
data has statistical considerations as its basis. Finney 
(1971) demonstrates how biological data of dose versus 
response are typically skewed and a logarithmic transforma-
tion results in a normal frequency distribution thereby 
rendering a.~alysis of the data to the application of linear 
regression and correlation models. The assumption of lin-
earity over a large portion of the dose-response curve is 
unjustified except for rough approximations (Goldstein, 
1967). The use of more accurate methods of determining 
values of inhibitory constants such as probit analysis can 
be used for critical experiments. The objectives of these 
experiments are most conveniently served by the graphic 
method described. 
The results of calculated rc50
1 s are compared with 
published results for serotonin, norepinephrine and dopa-
mine in tables?, 8 and 9 respectively. Review of these 
results indicates that the obtained values correlate well 
with published values. The generalizations described in the 
literature review for the uptake blocking characteristics 
of tertiary versus secondary amines is supported by the data 
summarized in tables seven through nine. Tertiary amines 
appear more effective in blocking serotonin uptake whereas 
secondary amines are potent inhibitors of norepinephrine 
uptake. There appears to be no obvious separation of effects 
Table 7. Norepinephrine uptake IC~0 's* for representative secondary and tertiary 
amines of the tricyclic antidepressant class of drugs. 
second~y 
PRO 
0.06 
0.043 
(4) 
DMI 
0.03 
0.03 
0.05 
0.006 
0.008 
0.003 
0.075 
(2) 
IMI 
0.2 
0.15 
1.0 
0.028 
2.4 
(4) 
tertiary 
AMI 
0.055 
0.054 
0.1 
(2) 
DOX 
0.65 
0.51 
(2) 
Reference 
Ross and Renyi, 1967a 
Shaskan and Snyder, 1970 
Horn et al., 1971 
Carmichael and Israel, 1973 
Maxwell et al., 1974 
Ross and Renyi, 1975 
This study 
(number of experiments) 
*Ic50
1 s expressed in micromolar (uM) 
'° 0 
Table 8. Serotonin uptake IC~ 0 1 s* for representative secondary and tertiary amines of the tricyclic antidepressant class of drugs. 
secondary tertiary 
PRO DMI IMI AMI DOX Ref er enc es 
0.285 0.49 Horn and Trace, 1974 
1.1 0.14 0.18 Ross and Renyi, 1975 
2.3 2 0.5 0.5 Squires, 1974 
4 Ross and Renyi, 1969 
5.8 0.5 Carlsson, 1970 
8 . 3 2.7 Shaskan and Snyder, 1970 
2.7 3.3 0.3 0.67 Buus Lassen et al., 1975 
4 6.0 0.6 0.8 Kannengiesser et al., 1973 
9.1 4.5 0.1 --- 2.5 This study (4) ( 2 ) (4) ( 2 ) (number of experiments) 
*IC50
1 s expressed in micromolar ( uM) 
\.D 
~ 
Table 9. Dopamine uptake ICs 0 's* for representative seconday and tertiary amines of the tricyclic antidepressant class of drugs. 
secondary 
PRO 
6 
5 (4) 
DMI 
80 
50 
50 
(2) 
IMI 
8 
16 
(4) 
tertiary 
AMI 
4 
4 
(2) 
DOX 
25 
References 
Ross and Renyi, 1967 
Horn et al., 1971 
This study 
(number of experiments) 
*Ic50
1 s expressed in micromolar (uM) 
~ 
f\) 
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of eit:'.1.er secondary or tertiary amines with respect to t he 
inhibition of dopa.nine upta~e. 
x) Protriptyline - acute tine course 
The results of 6 animals in each treatment group given 
20 ng/kg protriptyline i . p. are presented in figure 10. A 
one- way analysis of variance a:pplied to the data could not 
demonstrate t:'.1.e differences seen in this figure to be stat-
istically significant . The data from an additional twelve 
animals were combined for the control and 6 hour treated 
groups . The results of a comparison of treatment means 
using a two- tailed t-test demonstrated significance at the 
P . 05 level . Variability in this system has been sh own to 
be high throughout preliminary investigations of intra-
peri toneal administration of these drugs with subsequent 
testing in-vitro . It is important to note that the number 
of subjects in the acute as well as the subacute study 
represent individual animals. The variability of the steady-
state levels of tricyclic antidepressants in plasma has been 
shown to be high (Asberg et al . ,1971) and this phenomenon 
may be reflective of the high variability observed in these 
results . In any event, there appears to be an effect of 
blocking the uptake of 1- NE on acute administration of the 
drug after six hours. 
xi) Protriptyline - subacute time course 
Preliminary investigations using a dosage schedule of 
20 mg/kg daily resulted in t he death of a number of animals 
within 8 to 14 days . In virtually all cases of death, 
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distension of the abdomen was obvious . Aut opsies performed 
on t he animals revealed t t e lower i ntestine to 1J e filled 
with gas w:r.. er eas t h e upper intestine and s t omach was fill ed 
with par t ially digested food . I t was con cluded that pro-
nounced anticholinergic activity of the drug resulted in 
paralysis of peristalsis with death due to starvation . 
Gross behavioral observations of t h e animals prior to death 
s howed progressive weakening with diminish ed locomotor 
activity . The dose employed for t he subacute and chronic 
study was reduc ed from 20 to 10 mg/kg to insure t h e survival 
of t h e animals during the chronic study an d prov·ide a sourc e 
for comparison to the suba.cute study . 
Fi gure 11 illustrates t h e results ob tain ed from 10 
animals per condition administered 10 mg/ kg protriptylin e 
i . p . Once a.gain application of a.n analysis of variance to 
t h e data. did not result in statistically significant results . 
The reduction of uptake observed a.t 2 hours was 18% of 
saline injected controls (S . I. C. ) . Application of a number 
of statistical methods including Winsorizing an d Tri ;nming 
(Winer , 1971) did not result in establishing differences 
b etween treatment means . The results t h en can only be ta.ken 
as suggestive of a.n effect at 2 hours . 
Ten metabolites for t h e tertiary amin e ~ i mipramine , 
have been identified an d t h e degree of ca.t a.bolism of all 
but t he conjugated species have been studi ed in- vitro using 
a rat liver microsomal pre-pa.ration (Bickel,19 66) . The 
tertiary amine is cata.bolized to its corresponding sec ondary 
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Figure 11. Time course for the sub-acute administration of 
protriptyline upon the uptake of H~-1-NE into 
hypothalamic crude synaptosomal homogenate. 
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a.mine a."1.d this represents t h e only major metabolite formed 
in-vitro. The secondary a.mine attains peak plasma levels 
within two hours. Subsequent metabolism of t he secondary 
amine to a pr i mary amine or N-oxidati on or ring hydroxyla-
tion is less than 1 CY,'~ of t h e total substrate concentration 
within the parameters of the in-vitro test. These results 
may reflect the metabolism in-vivo and may account for the 
time course observed in the acute study. 
Subacute administration, however, does not lead to a 
clearly interpretable time course for the effect of uptake 
inhibition. In fact, variability is extremely hi gh at this 
point with noticeable, although not statistically signifi-
cant, increases in uptake above controls which may suggest 
a reb ound phenomenon of t h e neuronal ending to re-capture 
lost neurotransmitter. Th e subacute data of figure 11 can 
be interpreted in another way . Instead of postulating a 
clear-cut but relatively ineffect ive decrease i n unt ake at 
two h ours as well as a small reoound i ncr ease above controls 
a.t six and twelve hours, it is possible to view the results 
a.s simply no effect after six days of drug. The former view 
has much conjecture associated with it, t he latter is more 
nearly that necessarily obtained by strict stat istical int er-
pretation of the results . 
xii) Protriptyline - chronic t i me cours e 
The results of chronic (1 8 days) administration of 
protriptyline upon the uptake of 1-NE into hypothalaoic CSH 
are deuicted in fi gure 12. Application of a one- way analysis 
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Figure 12. Time course for the chronic administration of 
protriptyline upon the uptake of H3-l-NE into 
hypothalamic crude synaptosomnl homogenate. 
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of variance resulted in rejection of the hypothesis of equal 
oeans (F3 , 16 = 10.52, P .01) and the assumption of homogen-
eity of variance was not violated as determined by an Fmax 
test. Subsequent comparison of the treatment means was per-
formed using the Student-Neuman-Keuls multiple range test 
and demonstrated statistically significant differences at 
P .01 for control versus two hours , control versus six hours 
and twenty-four versus two hours . Treatr:ient at twenty-four 
versus six hours was shown to be significant at P . 05, 
whereas, no statistically significant differences could be 
demonstrated for either the two versus six hour or control 
versus twent-four hour treatment groups. 
The measure of dispersion about the means reuresented 
in figure twelve are standard deviations and not standard 
errors of the means as used in the acute and subacute figures. 
Although twenty-five animals were used in each treatment 
condition, the effect of pooling allows them to be represent-
ed only as an n. = 5. Even with relatively low n. compared 
l l 
with previous studies, the data obtained are so precise 
that it may be concluded that the effect of pooling serves 
to mask the individual variability c~nsiderably. 
One additional point worthy of discussion is that of 
the variation observed between the control groups of the 
acute, subacute and chronic studies. The weights (and ages) 
of the animals used in each of these studies varied consider-
ably because selection of the animals used in these studies 
was based pri~arily upon animal availability. In the acute 
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group the animals weighed approximately 300 grams and t h e 
uptake value for t h e controls in t hat group was approximately 
0 . 6 as indicated in fi gure 10 . Th e suba.cute study employed 
animals weighing 450 grams and the control uptake value of 
0 . 3 can b e ob served from fi gure 11 . Finally , the chronic 
group employed 200 gram animals and t heir control values 
wer e 0 .9 as depicted in figure 12 . It is easy to conclude 
that uptake is inversely proportional to the age or weight 
of the animal . Although each group had its own control , a 
good argument can be made for t h e inappropriateness of 
comparing the results between groups because two variables 
ar e known to differ i . e . treatment and the age of the anioals. 
The argument is difficult to refute on t heoretical grounds 
and no attemut to do so will be persued . Instead, these 
experiments will be repeated with post- pubertal a.Dimals prior 
to publication. 
A comparison of the maximal percent of uptaxe i nhibition 
with respect to t heir own saline injected controls in t he 
a cute , subacute and chronic studies are 56, 18 and 48 percent, 
respectively . If the consideration noted in t he preceding 
I 
paragra~h turns out to be u..Djustified , then these values 
alone suggest that uptake inhibition is prominant during 
either acute or ch..ronic administration and not nearly as 
effective during subacute administration of protriptyline . 
The results may suggest t hat chronic adm nistration of pro-
tri~tyline results in a long lasting inhibition of the 
transport carrier for l - 3E uptake into the hypothalamic CSE, 
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unlike the results of the subacute experiment . Since upt a ke 
after subacute administration may be considered neither 
prolonged nor unidirectional, it appears that therapeutic 
effectiveness would not be anticipated during subacute ad-
ministration and this reflects the clinical picture very 
accurately. The prolonged effect upon chronic administra-
tion appears predictive of a therapeutic response and is 
clearly temporally related to the therapeutic effect observ-
ed cl:i;nically. These results support the hypothesis that 
tricyclic antidepressants may work by blocking re-uptake 
of endog enous neuxotransmitter in-situ . 
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CHAF·T&'t IV : GENERAL DISCUSSI ON 
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A. Interpretive constraints 
One of the principal responsibilities of a scientist is 
to attempt to remove or at least counter- balance the bias 
which permeates his or her line of investigation . A good 
deal of bias is corrected for with the proper use of controls 
but much bias remains at the level of assumptions made prior 
to the experimental design . Three assumptions have been 
made and are discussed here to alert the reader to the lim-
itations of the interpretations made h oth in t h e preceding 
chapter and the conclusions to follow . Th e first deals with 
t h e assumption of unidirectional transmembranous fl ux of 
n eurotransmitter into synaptosomes and h ow this ph enomenon 
may confound the measurement of uptake . The second assump-
tion is t hat of no effect of endog enous neurotransmitter 
levels upon uptake . Fi nally t he assumpt ion of equival ent 
protein binding of tricyclic antideuressants to phys iological 
proteins present in t he incubation medi um is discussed . 
Much of t h e experimental work reported here is concern-
ed with t he characterization of the synaptosoma.1 system used 
to study t h e effects of intraperitoneally a dmi n istered drugs 
by subsequent in- vitro testing . The characterization lends 
credibility to the proper functioning of the system in t hat 
it clearly demonstrates the degree to v1h ich this system cor.i-
pares with those used by other investigat ors . However , in 
no way does it resolve critical issues with r espect to the 
transport of 1- norepinephrine into synaptosome s . 
On e such issue remaining unresolved is t hat regarding 
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the extent to which neurotransmitter exchange processes 
occur and may confound the measurement of a.-ri estima.te of net 
uptake . .An approach to resolving this question may be to 
measure the specific activity of neurotransmitter located 
in the incubation medium, the synaptosomal cytoplasmic as 
well as vesicular fractions separately both before ~vid 
after incubation at physiological temperatures. The results 
of these experiments may indicate whether endogenous neuro-
transmitter stored within vesicles, the cytoplasm or that 
resulting from de novo synthesis somehow contributes to-
ward an exchange process • 
.Another unresolved question is that of the relationship 
between endogenous neurotransmitter content and the uptake 
of exogenously applied neurotransmitter. A review of the 
literature suggests that endogenous biogenic amine levels 
are lowered upon chronic administration and turnover 
appears to be increased. These effects appear intuitively 
concordant with what one might expect of uptake inhibitors , 
however, this interpretation presupposes that the effect of 
uptake inhibition is responsible for the lowered levels. 
The evidence comes from demonstrating the uptake inhibitory 
characteristics of the tricyclic antidepressants as measured 
in-vitro. Lowered levels of endog enous amines may ~e re-
s-ponsiole for a decrease in uptake and if t his is so, the 
inhibition of uptake observed may be an indirect effect of 
t he drug . This important question seems experimentally 
approachable by comparing the effects of biogenic amine 
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synth esis inhibitors upon uptake measured both in- vitro and 
after parenteral administration with subs equent testing in-
vitro . The data presented in this thes~s with respect to 
neurotransmitter refilling of previously emptied synapto-
somes sugg ests that levels of neurotransmitters can affect 
uptake . Snyder and Coyle (1969) renorted a decrease in up-
take of norepinephrine in animals previously treated with 
reserpine as opposed to saline injected controls . In 
addition it is important to realize that compartmentation 
of neurotransmitter within the neuronal ending may affect 
uptake differentially . Investigation of the pharmaco-
dynami c s of the tricyclics with respect to uptake inhibition 
should consider the effect of pool sizes as well as total 
levels of endogenous neurotransmitters . 
The potencies of the tricyclics as uptake inhibitors 
are taken from conc entration terms in- vitro whereas it has 
been shown that the binding of tricyclic antidepressants 
to plasma proteins is variable and does not reflect a clear 
separation of effects between secondary and tertiary amines 
(Barga et al ., 1969) . The in-vitro experiments therefore · 
necessitate an assumption of equivalent "::l inding to plasma 
proteins for a direct domparison of potency to be considered 
legitimate . ProtriptyJ,ine and desmethylimipramine are 
b ound to plasma proteins leaving only 8 . 0 and 8 . 4 percent 
free in the plasma, respectively. Imipramine and amitrip-
tyline are free in plasma to the extent of 4 . 2 and 3 . 6 per-
cent, respectively . : ortriptyline however , i s 94 .5 percent 
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bound . Since free drug is considered to be pharmacological-
ly active whereas t hat boun d to plasma proteins are inactive , 
the relative degree of bindi ng may be an i:nportant variable 
in ascertaining meaningful potency ratios i n - vitro and in-
vivo (Glassma..n. et al., 1977) . Although much work ha.s been 
done in an attempt to correlate blood plasma levels with 
the therapeutic effect (Alexanderson et al., 1973), little 
has been reported on the relationship between t h e concentra-
tion of free drug and clinical outcome (Glassman et al ., 
1973, Muscettola et al., 1978 ). 
B. Alternative mechanisms 
Caution must be taken at this time to refrain from 
concluding that tricyclics mediate their t herapeutic ef-
fects by uptake inhibition or blocxade. The spectrufil of 
phar macological activity of the tricyclic antidepressants 
is not limited to uptake blockade . In fact, two additional 
biochemical effects are being suggested as possible deter-
minants of the therapeutic effect of the tricyclics . 
Edwards and Burns (1974) demonstrated t he ability of tri-
cyclics to block MAO found in human platelets and rt.0th and 
Gillis (1974) reported an ·1AO inhibitory effect of tricyc-
lies in rabbit brain mitochondria . 
Alternatively, tricyclics possess reasonable strong 
anticholinergic effects demonstrated both peripherally , 
using antagonism of carbachol contraction of the guinea pig 
ileum, a...'1d centrally by displacement s of E3-quinuclidinyl 
benzylate, a potent muscarinic antagonist, from homog enates 
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of rat brain (Sayers and Burki , 1976; Snyder and Yammamura , 
1977). Janowsky et al. (1972) review the evidence for the 
efficacy of anticholinergics in the treatment of depression. 
In addition to the effects suggested as components of 
the thymoleptic effect, tricyclics possess other therapeutic 
effects when administered in doses below that required for 
the treatment of depression. Wilkerson (1978) reported o 
the ability of tricyclics to reverse ouabain induced ventric-
ular arrhythmias in dogs at doses below that used for the 
treatment of depression. Similarly , protriptyline has b een 
demonstrated to be effective in the treatment of hyp ersornnia 
and t he narcolepsy-catalepsy syndrome after a single bed-
time dose of 10 mg (Schmidt et al., 1977). 
Other clinically effective antidepressants exhibit 
different pharmacological profiles than the tricyclics . 
Mianserin is not a very potent inhibitor of catecholamine 
or serotonin uptake (Goodlet et al., 1977). Eomifensine 
possesses weak a.nticholinergic activity but is very potent 
inhibitor of dopa:nine uptake and has clinical psychostimu-
latory properties (fiunt et al., 1974). 
Comparisons of the performance of tricyclics as well 
as other clinically effective antidepressants in a number of 
biochemical systems may serve to demonstrate the extent to 
which each property (i.e. anticholinergic, uptake inhibition, 
receptor binding affinity, Vi.AO inhibition, etc .) may either 
contribute to or be nredictive of either the thymoleptic 
effect or side effects. These comparisons may suggest a 
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role for specific neurotransmitters or a balance of neuro-
transmitters in depression or any of t h e other clinical 
entities in which tricyclics are or can be used. 
One type of comparative technique is demonstrated in 
table 10. The table was compiled from all in-vitro dat~ 
reviewed in tables 7 - 9 as well as t he anticholinergic data 
of Shein and Smith (1978). Inclusion of the anticholiner-
gic potencies was based upon availability of comparative 
data for the particular tricyclics investigated and reported 
in this thesis. Unfortunately , comparative data across a 
number of seconday and tertiary amines are not available 
for the other uronerties mentioned. 
- .. 
3efore proceeding it is important to point out that a 
similarly compiled table may possess a great deal more 
predictive value if each of the biochemically determined 
potencies were measured after chronic parenteral administra-
tion of the drug. As Inch et al. (1973) point out, the com-
parison of drug effects in-vivo can only be considered valid 
if the time course for the effect of each drug is deter-
mined and the time representing the optimal effects are used 
to determine potencies . This would necessitate perforoing 
a time course for each drug after chronic administration . 
The in-vitro comparisons then are performed with the under-
standing that they might not reflect the actual relative 
potencies which may occur upon c~ronic administration of 
the drug, however , it represents a starting point and a 
source of comparison for data which will no doubt become 
Table 10. Summary of relative and absolute potencies of re~resentative secondary and 
tertiary amines of the tricyclic antidepressant lTCA) class of drugs. 
Sub POTENCIES RELATIVE POTENCY RATIOS 
clase DRUG UPT-.AKK Ic20 Ts T uM/ * ** R Ach P 5-HT DA 5-HT Ach Ach Ach of 
TCA 5-HT NE DA rm- NT DA 5-HT NE DA 
s + + + 5.3-1.4 .015-. 01 5.5-.5 E PRO 2.18 104 108 .964 .411 42.7 .396 
c +(5) (2) (2) 
*< o. 9%' (98.1%) (0.9%) 0 
N 
3.3:!:.67 + 60.± 10 D .025-. 01 
.006 A DMI 0.33 132 2600 .055 .100 13.2 
~. (9) (7) (3) (0. 7%) (99.2%] (0.04%) 
+ + 12:!:4 T .33-.09 1o75-.45 
.028 3.03 1.30 .083 E IMI 1.00 .440 16.0 
R (5) (5) (2) ( 68. 6%} (29.5%, (1.8%) 
T 
I + + 4 :!: 0 
.53-.1 i-07-. 01 A AMI 4.17 7.57 57.0 .133 7.86 59.6 .959 R (5) (4) (2) ( 11. 4%) (87.1%, ( 1.4%) y 
+ + -2.9-.4 .58-.7 . 25 
.116 .145 .724 .017 DOX 0.42 5.00 43.0 (2) (2) (1) ~ 16. 3%) (81.7% (1.9%) 
* wean% s.e.m. tal~ulrted+f%om indtviduat igvjfti~a.,orf' lesults pres.rnt3c Tn ~al)Jes7--g. 
+= of independen s ud es. =0o of to a an ic o ne ~ c nf uence descr be in the text. 
** R Ach P = Relative Anti-cholinergic Potenci obta ned from Shein & Smith! 1978. PRO=protriptyline IMI=imipramine D X=doxepin NE=norepinephr ne 
DMI=desmethylimipramine AMI=amitriptyline 5-HT=serotonin DA=dopamine 
...... 
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a vailable with future research . 
To the left of the vertical doubl e line in table 10 a.re 
the uptake inhi bitory potencies of t he t ricyclics with r es-
pect to three neurotransmitters a s well a s the relative (to 
i miuramine) anticholinergic potencies . The relative potency 
ratios for serotonin , norepinephrine and dopamine, r eferred 
to as t he biogenic a.nine ratios, can be comnared with one 
another but t h e anticholinergic:biogeni c ami ne ratios, in 
t he last three columns of table 10, cann ot be compared 
directly with t h e biogenic amine ratios simpl y because a 
different response measure was used i n determining t he 
anticholinergic influence. The values obtai ned for the 
anticholinergic:biogenic amine ratios become more meani ngful 
when viewed as a percent of t he total anticholinergi c influ-
ence with resuect to each of t h e bi ogenic amines. ~he values 
placed within parentheses directly below the anticholinergic: 
biogenic a.mine ratios were obtained by summing the t hr ee 
ratios for a single drug and expressing each ratio as a 
percent of t h e total. 
Several portions of this table demonstrate interesting 
correlations with lmown effects of tricyclics. Based upon 
the biogenic amine comparisons in the first three columns to 
t h e right of t h e double line, t here appears to be n o differ-
ence between the effects of amitriptyline an d doxepin. 
Clinical studies do not demonstrate any clear differenc es 
between doxepin and amitriptyline as antidepressants (Beck , 
1973). Doxepin has been reported to be well tolerated by 
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older patients because of fewer incidences of anticholiner-
gic side effects . This difference is clearly reflected in 
the potencies of anticholinergic effects where amitriptyline 
is ten times more uotent than doxepin. This may sugg est 
that the anticholinergic properties are not i mp ortant for 
t he clinical therapeutic effect . Cairncross et al . (1 963 ) 
sugg ested t hat the a."'1.ticholinergic effect was imuortant for 
therapeutic activity but :B lackwell ~al . (1972) concluded 
that the antic~olinergic effect was related more to the 
sedative properties of the drugs . This is difficult to 
reconcile since stimulation of locomotor activity , a 
behavioral resuonse measure which could be vie·wed as an 
inverse indicator of sedation , has been shown to be centrally 
mediated by anticholinergic drugs (Aquilo:'.lius et a.l. , 1972) . 
It may be that the difference in anticholiner gi c potency is 
only reflected in the periphery with these two drugs . The 
particular proportional indluences upon the biogenic amine 
syste:ns may serve to mask any psychostimulatory properties 
these drugs possess if they were purely anticholinergic . 
This may occur as a result of the lack of proportional 
influences within the periphery that these neurotransmitter 
systems may possess within the central nervous system . A 
look at the anticholinergic: biogenic amine ratio 11 perc ent" 
figures of table 10 sugg ests that there are no differences 
in the relative effects of a.Dticholinergic to biogenic 
amine influences between amitriptyline and doxepin. It 
may be as a. result of this balancing influence that doxeuin 
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and aoitriptyline are sedative. 
On the other end of the pharmacological suectrum is 
the psychostimulatory effects of protriptyline. Protr ip-
tyline is the only tricyclic antidepressant recommended by 
a manufacturer for use in anergic :patients . Since dopamin-
ergic influences are believed to be responsible for 
stimulating effects on locomotor activity (?ibiger et al., 
1973; Creese and Iversen , 1973; 1975; ~seug and Loh , 1974; 
Tseug et al., 1974) and cholinergic-dopaminergic inter-
actions are important as well (Klawans, 1968 ; Hornykiewicz , 
1966; Friehoff & Alpert , 1973) , it seems reasonable to con-
clude that a cholinergic -dopaminergic interaction ma.y 
mediate the psychostimulatory effect of this drug . Compared 
with desmethylimipramine, the percent of anticholinergic-
dopa.minergic interaction is 22 times greater for protrip-
tyline whereas the effects with respect to anticholinergic-
norepinephrine or anticholinergic-serotonin influences are 
norepinephrine or a.nticholinergic-serotonin influences are 
comparable. This may reflect the mechanism of psychostimu 
lation occuring in-vivo. 
This approach may offer a reasonable, although 
admittedly speculative, interpretation for the different 
effects observed with the clinical use of tricyclics, but 
most important is the therapeutic effect. Review of the 
relative potency ratios for biogenic amines demonstrates 
the common factors which may suggest how all these drugs 
ma.y work with respect to the neurotransmitters studied. All 
113 
dopamine:norepinephrine ratios a.re greater t han one and all 
serotonin :dopamine ratios are less than one. Considering 
only the b iogenic amines, t his is t h e onl y factor common 
to all tricyclics reflected in table 10. It may b e sugg ested 
t hat t he relative effects of serotonin with respect to 
dopaoine and norepinephrine with respect to DA are involved 
.i n the antidepressant effect of t hese drugs . 
Cont inuing with t h e concept t hat a balance of effects 
upon critical neurotransmitters may be responsible for the 
t herapeutic effect , t hese observations are remi nisent of 
t he elements of the "permissive hy pothesis of depressionP 
(Prange et al ., 1974) . This hypothesis stat es that s ero-
tonin acts as a gating or controlling influence for the 
expression of either mania or depression by :ncreased or 
decreased levels of norepinephrine , respectively . Agents 
aff ecting t hese systems perhaps with respect to a third 
buffer or reference system such as t he dopaminergic system 
may account for t he comm on dimension requir ed for a unified 
neurotransmitter hypothesis of affective disorders . 
An attempt to explain t h e mechanism of action of t hese 
drugs using only four of possibly scores of neurotran smitters 
is admittedly premature . Certainly other mechanisms may 
be responsible for the t herapeutic effect both within as 
well as outside the frame work of the biogenic amine 
hypothesis. 
It is i mportant to nore that t he develo pment of the 
tricyclics came out of investigations with antihistaminic 
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drugs are tricyclics possess antihista~inic properties . 
Research directed towards evaluating these properties may 
reflect more light on even more complex interactions then 
we dare to expect. Knowledge of the role of neurotrans-
mitters in behavior is still at its infancy (Ealdessarini, 
1975). Until more data is accu:nula.ted with respect to the 
pharmacokinetics , physical properties and phar::na.codynamics 
of tricyclic antidepressants, table like that of table 10 
represent a way in which leads toward a particular line of 
investigation may be obtained. A glimmer of hope in unrav-
elling the complex interactions of a number of variables in 
biological systems is the increasing applications of statis-
tical methods. Techniques of utilizing parametric and non-
parametric statistical methods are becoming more accessible 
and easier to apply. Pattern recognition tecrL~iques are 
available to a.id in the analysis of complex interactions 
using cluster analysis, path analysis, principal components 
and other multivariate approach es (Rarper, et a~, 1977). 
c. Conclusion 
Should the limitations noted above prove to be n eglie -
i ble, t hen it would appear that protript:rline blocks t h e 
uptake of norepinephrine upon chronic adoinistration whereas 
when administered sub-acutely uptake blockade is not clearly 
discernable . These findings demonstrate a te~poral corre-
lation of untake blockade with clinical effectiveness in 
humans and lends support to both t he catecholamine hypo t hesis 
and the propo sed mechanism of action of tricyclics as uptake 
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blockers . In addition it is i nteresting to note that there 
is a risk of attempted suicide in deuressives during t he 
initial days of ch emotherapy (Beck , 1973) and sub- acute 
admi nistration displays hi ghl y variable effects and per haps 
even some potentiation of uptake t hereby enhancing t h e 
functional depletion of neurotransnitter at the level of 
the uost synaptic receptors . This effect could exulain t he 
clinical observation of increased suicidal tendency during 
initiation of tricyclic chemotherapy . 
In support of the sub- acute data obtained is the evi-
dence that twelve hours post- protr iptyline using either 
serotonin or tryptarnine as substrate , MAO activity is ele-
vated ( Ed Kaiser- pers onal communication) . An increase in 
uptake provides more substrate for r~AO t herefore t hese 
results appear corroborative of the subacute data presented 
here . 
It appears that the relative anticholinergic properties 
can be predictive of the psychostimulatory effects of pro-
triptyline . Comparisons of the effects of drugs using 
in- vitro biochemical techniques may be useful in formulating 
hypotheses regarding the mechanism of action of the tricyclic 
antidepressants . The lack of psychostimulatory action of 
the most potent anticholinergic of the tricyclics, ami -
triptyline , may be explained by a relative interaction 
between anticholinergic and dopaminergic influences . 
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Figure A-1. Flbwchart for "VIVO": A program used to 
calculate data for synaptosomal uptake studies 
ST&.qT 
I NPUT 
DATA 
no 
CALCULATE 
unadjusted 
P/ M & l/P 
PRINT 
unadjus • 
P/M&l/ 
FINISH 
CALCULATE 
adjusted 
P/M , l/P & 
mg . protei 
PRINT 
adj. P/ M 
l/P & 
• nrot . 
FINISH 
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Table A-1. Listing of 'VIVO': A program used to cal-
culate data for synaptosomal uptake studies. 
vivo '15:47 sun 2 3 j an 7 7 
100 dlm z(lOO), 1 (100), m(lOO), n(100), q(lOO) 
110 dim .r(lOO), g(SO), h(SO), j(lOO), y(100) 
120 dim i(lOO), s(lOO), w(lOO), p(lOO), e(100) 
130 dim a(lOO), b(lOO), c(l00), d(l00), f(100), t(l00) 
140 print 'experiment number?' 
150 Input n$ 
160 print 
170 print 'specify n (where n =I of reaction vessels):', 
180 Input n 
190 print 
200 print 'enter cpm data, in order, from the 1 !quid' 
210 print 'scintillation spectrometer printout.' 
220 print 'enter each value Individually by pressing' 
230 print 'the return key after each entry.' 
240 print 
250 print '37 degrees; serotonin; Incubation media values' 
260 for k = 1 to n/6 
270 Input l(k) 
280 next k 
290 print 
300 print 1 37 de~rees; noreplnephrlne; incubation media values' 
310 for k = n/6+1 to n/3 
3 2 0 i n put I ( k) 
330 next k 
340 print 
350 print 1 37 degrees; dopamlne; Incubation media values' 
360 for k = n/3+1 to n/2 
370 Input l(k) 
' 380 next k 
390 print 
400. prlnt " '37 degrees; serotonin; supernatant ·values' 
410 for k = 1 to n/6 
420 input s(k) 
430 next k 
440 print 
450 print '37 degrees; norepinephrtne; supernatant values' 
460 for k = n/6+1 to n/3 
Ii 7 0 i n p U t S ( k ) 
480 next k 
490 print 
500 print '37 degrees; dopamine; supernatant values' 
510 for k = n/3+1 to n/2 
520 input s(k) 
530 next k 
540 prlnt 
550 print 1 37 de~rees; serotonin; wash values' 
560 for k = 1 to n/G 
570 input w(k) 
580 next k 
590 print 
600 print 1 37 de~rees; norepfnephrine; wash values' 
610 for· k = n/6+1 to n/3 
620 input w(k) 
630 next k 
640 print 
650 print 1 37 degrees; dopamine; wash values' 
660 for k = n/3+1 to n/2 
670 input vdk) 
680 next k 
690 print 
700 print 1 37 degrees; serotonin; pellet values' 
710 for k = 1 to n/5 
720 input p(k) 
730 next k 
740 print 
750 print 1 37 degrees; norepinephrine; pellet values' 
760 for k = n/6+1 to n/3 
770 input p(k) 
780 next k 
790 print 
800 print ''7 degrees; dopamine; pellet values' 
810 for k = n/3+1 to n/2 
820 Input p(k) 
830 next k 
840 print , 
850 print 'zero degrees; serotonin; incubation media values' 
860 for k = n/2+1 to 2*n/3 
870 input i(k) 
380 next k 
890 print 
900 print 'zero de~rees; norepinephrine; incubation media values' 
910 for k = 2*n/3+1 to 2*n/3+n/E 
920 input I (k) 
930 next ·k 
940 print 
950 print 'zero degrees; dopamine; Incubation media values' 
960 for k = 2*n/3+ri/6+1 to n 
970 Input i (k) 
980 next k 
990 print 
1000 print 'zero degrees; serotonin; supernatant values' 
1010 for k = n/2+1 to 2*n/3 
1020 input s(k) 
1030 next k 
1040 print 
1050 print 'zero de~rees; noreplnephrine; supernatant values' 
1060 for k = 2*n/3+1 to 2*n/3+n/6 
1070 inout s(k) 
1080 next k 
1090 print 
1100 print 'zero de~rees; dopamine; supernatant values' 
1110 for k = 2*n/3+n/6+1 to n 
1120 Input s(k) 
1130 next k 
1140 print 
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1150 pri.nt 'zero degrees; serotonin; wash values' 
1150 for k = n/2+1 to 2*n/3 
1170 input w(k) 
1180 next k 
1190 print 
1200 print 'zero de?,rees; noreplnephrine; wash values' 
1210 for k = 2*n/3+1 to 2*n/3+n/6 
1 2 2 0 I n pu t w ( k ) 
1230 next k 
1240 print 
1250 print 'zero degrees; dopamine; wash values' 
1260 for k = 2*n/3+n/6+1 to n 
1270 input w(k) 
1280 next k 
1290 print . 
1300 print 'zero degrees; serotonin; pellet values' 
1310 for k = n/2+1 to 2*n/3 
1320 Input p(k) 
1330 next k 
1340 print 
1350 print 'zero degrees; norepinephrlne; pellet values' 
1360 for k = 2*n/3+1 to 2*n/3+n/6 
1370 input p(k) 
1380 riext k 
1390 print 
1400 print 'zero degrees; dopamine; pellet values' 
1410 for k = 2•n/3+n/6+1 to n 
1420 input p(k) 
1430 next k 
1440 print 
1450 print 'were there any changes in the experimental design?' 
1460 input a$ 
1470 If ~$ = 'no' then 1640 
1480 if a$ = 'yes 1 then 1490 
1490 print 
1500 print 'enter the following values:' 
1510 print ;'incub. med. vol. (ml.), its sample aliquot (ml.): 1 
1520 Input fl, #2 
1530 print ;'wash vol. (ml.), its sample aliquot (ml.):' 
1540 input 13, #4 
1550 print ; 'pet let (sol. vol.Isam. vol.):' 
1560 input #5 
1570 print ;'sup. sample aliquot (ml.):' 
1580 input 16 
1590 print ;'brain homogenate sample volume (ml.):' 
1600 input 18 
1610 #7 = ll - 12 
1620 print 
1630 go to 1730 
1640 #l = 4.0 
1650 12 = 0.1 
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1660 13 = 6.0 
1670 1i. = 0.1 
1680 15 = 1.575 
1690 16 = 0.1 
1700 17 = 3.9 
1710 18 = 0.2 
1720 print 
1730 def fna(k) = p(k) * 15 
1740 def ·fnr(k) = int(l0**6/fna(k))/100 
1750 def fnb(k) = w(k) * #3/#4 
1760 def fnc(k) = s(k) * 17/#6 
1770 def fnd(k) = (fnc(k) + fnb(k))/#7 
1780 def fne(k) = int(-10**4*(i (k)*#l/#2 - (fna(k)+fnb(k)+fnc(k 
)))/(i(k)*#l/#2))/100 
1790 def fnf(k) = int(l0**5*fna(k)/fnd(k))/l00 
1800 print 
1810 print 
1e20 input 
1830 if c$ 
1840 print 
'do you have 
c$ 
the results of the protein assay?' 
= 'yes' then 2220 
'pause for paper Insertion-press return key when rea 
dy' 
1850 
1860 
1870 
1880 
1890 
1900 
1910 
l!J20 
1930 
1940 
1950 
1960 
1970 
1980 
1930 
2000 
20Hl 
2020 
2030 
2040 
2050 
2060 
2070 
2080 
2090 
2100 
2110 
2120 
2130 
2140 
2150 
2160 
2170 
2180 
2190 
pause 
print, 'experiment I', n$ 
print 
print 
pr Int 
print 
print 
print 
,,;;;;'unadjusted' 
;;'sample no.';;;'% error';;;;'p/m 1 , 1 l/p 1 
,, I (exp- 3) I, I (exp- 4) I 
print ,'37 degrees' 
print 
for k = 1 to n/6 
print ;;;k;;;fne(k);;;fnf(k);;;;fnr(k) 
next 1< 
for k = n/6+1 to n/3 
print ;;;k;;;fne(k);;;fnf(k);;;;fnr(k) 
next k 
print 
for k = n/3+1 to n/2 
print ;;;k;;;fne(k);;;fnf(k);;;;fnr(k) 
next k 
pr Int 
print ,'zero degrees' 
print 
for k = n/2+1 to 2*n/3 
print ;;;k;;;fne(k);;;fnf(k);;;;fnr(k) 
next k 
print 
for k = 2*n/3+1 to 2*n/3+n/G 
print ;;;k;;;fne(k);;;fnf(k);;;;fnr(k) 
next k 
print 
for k = 2•n/3+n/6+1 to n 
print ;;;k;;;fne(k);;;fnf(k);;;;fnr(k) 
next k 
print 
143 
2200 go to 3410 
2210 print 
2220 print 'enter the results of the protein assay In the form' 
2230 print 1 (m,b,al,sl,a2,s2, ••• an,sn) where m and bare the' 
2240 print '.lowry re3ression coeff lcient an1 Intercept, respect 
Ive 1 y; ' · 
2250 print 'al to an are the absorbances and sl to snare their 
respective' 
2260 print 'sample sizes (ml.) used to obtain val Id absorbance 
readln~s' 
2270 print 'beginning with l=forebraln control, 2=1ow dose, 3=1 
O'r'J-med, 1 
2280 print '4=hi-med and 5=hi dose; 6-10 represent hypothalamus 
control to' 
2290 print 'hi dose samples and finally 11-15 are strlatal valu 
es. ' 
2300 
2310 
2320 
2330 
2340 
2350 
2'360 
2370 
2330 
2390 
2400 
2410 
2420 
2430 
2440 
dy' 
2450 
2460 
. 24 70 
2480 
2490 
2500 
t • I 
2510 
25 20 
2530 
2540 
2550 
2560 
2570 
2580 
25 90 
2600 
2610 
2620 
2630 
2640 
2650 
2660 
2670 
print ;;'Center 2 values per line)' 
print 
input m,b 
prf nt 
for k = 1 to n/2 
input g(k),h(k) 
next k 
def fnj(k) = lgt(g(j)) 
def fny(k) = (fnj(k)-b)/rn 
dim k{100) 
def fnk(k) = lnt{lOOO*{fny(k)*l8/h{j)/l0**3))/1000 
def fnl (k) = fna{k)/fnk(k) 
def fnm(k) = fnl (k)/fnd(k) · 
def fnn(k) = 10**5/fnl Ck) 
print 'pause for paper insertion-press return key when rea 
pause 
print 
print 
print 
print 
print 
, 'experiment I' ,n$ 
. . . . ' I I I I I 
'sample 
lowry adjusted' 
no '····~error'···· 'p/m' · · ·' 
• ' '' 0 'Ill Ill 
print ,;;;;' (exp-3)';;' (exp-5)' 
def fnq(k) = lnt{l0**5*fnm{k))/100 
def fnt(k) = lnt{l0•*2*fnn(k))/100 
dim o(30) 
dim u(30) 
print 
print , 1 37 degrees' 
print 
for k = 1 to n/6 
let j = k 
print ;k;;;fne(k);;;fnq{k);;;fnt(k);;;fnk(k) 
let o(k) = fnq(k) 
let u(k) = fnt{k) 
next k 
print 
for k = n/6+1 to n/3 
let j = k 
l/p', 'mg. pro 
2680 
2690 
2700 
2710 
2720 
2730 
2740 
2750 
2760 
2770 
2730 
2790 
2800 
2810 
2820 
2830 
2840 
2350 
2860 
2870 
2880 
2290 
2900 
2910 
2920 
2930 
2940 
2950 
2960 
2970 
2980 
29 90 
3000 
3010 
3020 
3030 
3040 
3050 
30GO 
3070 
3080 
dy' 
144 
print ;k;;;fne(k);;;fn~(kl;;;fnt(k);;;fnk(k) 
let o(k) = fnq(k) 
let u(k) = fnt(k) 
next k 
pr l.n t 
for k = n/3+1 to n/2 
let j = k 
print ;k;;;fne(k);;;fnq(k);;;fnt(k);;;fnk(k) 
let o(k) = fnq(k) 
let u(k) = fnt(k) 
next k 
print 
print , 'zero degrees' 
print 
for k = n/2+1 to 2•n/3 
let j = k-15 
print ;k;;;fne(k);;;fnq(k);;;fnt(k);;;fnk(k) 
let o(k) = fnq(k) 
let u(k} = fnt(k) 
next k 
print 
for k = 2•n/3+1 to 2•n/3+n/6 
let j = k-15 
print ;k;;;fne(k);;;fnq(k);;;fnt(k);;;fnk(k) 
let o(k) = fnq(k) 
let u(k) = fnt(k) 
next k 
print 
for k = 2•n/3+n/6+1 to n 
let j = k-15 
print ;k;;;fne(k);;;fnq(k);;;fnt(k);;;fnk(k) 
let o(k) = fnq(k) 
let u(k) = fnt(k) 
next k 
print 
print 
pr Int 
input 
if d$ 
if d$ 
print 
'do you wish to print p/m corrected for' 
'non-specific absorption?' 
d$ 
= 'yes' then 3080 
= 'no' then 3410 
'pause for paper insertion-press return key when rea 
3090 pause 
3100 print ,'experiment 1 1 ,n$ 
3110 print 
3120 print 'values reported are adjusted for non-specific absor 
pt ion' 
3130 print 
3140 print ;;;,'p/m' 
3150 print ;;; 'Cexp-3)(cpm/mg. proteln)/(cpm/ml. sup.)' 
3160 print 
3170 print 'serotonin' 
3180 print 
3190 for k = 1 to n/6 
3200 let j = k+lS 
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3210 pr Int ,;;o(k)-o(j) 
3220 print 
3 23 0 next k 
3 24 0 print 
3250 print 1 noreplnephrlne' 
3260 print 
3270 for k a n/ 6+1 to n/3 
3280 let J = k+l5 
3290 print , ; ;o(k)-o(j) 
3300 pr Int 
3 3 J. 0 next k 
3320 print 
3330 print 'dopamine' 
3340 pr Int 
3350 for k = n/3+1 to n/ 2 
3360 let . = k+lS J 
3370 print , ; ;o(k)-o(j) 
3380 print 
3390 next k 
3400 print 
)410 end 
